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ABSTRACT 
Influenza remains a leading cause of illness and death throughout the world, making it a 
serious health concern as well as a significant economic burden. While the role that the 
peripheral immune system plays in influenza is well-characterized, it is unknown if infection with 
this common viral pathogen can result in a central inflammatory response, neuronal damage, 
and long-term neurobehavioral effects. Therefore, the broad aim of this research was to 
determine if peripheral infection with live influenza virus elicits a neuroimmune response and 
impacts hippocampal structure and function.  
Initial studies determined that influenza infection induced deficits in spatial learning and 
memory in adult mice at day 7 post-infection. These cognitive impairments were paralleled by 
increased hippocampal expression of proinflammatory cytokines (IL1-β, IL6, TNF-α, and IFN-α), 
and the loss of neurotrophic (BDNF, NGF), and immunomodulatory (CD200, CX3CL1) factors. 
To better understand the cellular mechanisms underlying these effects, changes in microglia 
reactivity and hippocampal neuron morphology were assessed at the same timepoint in which 
heightened inflammation and cognitive deficits were evident. Influenza infected mice had 
increased microglial activation throughout the hippocampus, and exhibited significant alterations 
in the architecture of both CA1 pyramidal neurons and dentate gyrus granule cells. Taken 
together, these data suggest that neuroinflammation and changes in hippocampal structural 
plasticity may underlie cognitive dysfunction associated with influenza infection.  
The loss of immunomodulatory factors important for neuron-microglia interactions, along 
with reduced neurotrophic support, could leave the brain vulnerable to inflammatory damage 
during influenza infection. A potential strategy for increasing brain plasticity and resiliency and 
improving cognitive function is environmental enrichment. The enhanced social, cognitive, and 
physical stimulation provided by environmental enrichment has been shown to benefit brain 
function and behavior in many central nervous system (CNS) disorders, but its therapeutic 
potential during peripheral viral infection remains unknown. Therefore, the objective of the next 
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series of studies was to determine if long-term exposure to environmental enrichment could 
prevent and/or attenuate the negative impact of influenza infection on the hippocampus and 
spatial cognition. Continuous exposure to environmental enrichment during rearing and 
throughout influenza infection helped modulate inflammation, preserve levels of neurotrophic 
and immunomodulatory factors, and reduce deficits in hippocampal-dependent learning and 
memory. Overall, these data establish the potential for environmental enrichment to mitigate the 
detrimental effects of peripheral infection on CNS function and cognitive behavior.  
As lasting neurobehavioral changes have been associated with viral infection, it was 
next determined if neuroinflammation, reduced neurotrophic support, and cognitive dysfunction 
persisted during/following recovery from influenza infection.  Changes in the hippocampal 
expression of inflammatory, neurotrophic, and immunomodulatory factors were determined at 
timepoints corresponding to partial (day 14 post-infection) and full (day 25 post-infection) 
recovery from influenza infection. In addition, spatial learning and memory was assessed 
following recovery to determine if influenza infection induced prolonged cognitive impairment.  
At partial recovery from influenza infection, TNF-α and IL-1β remained elevated, and levels of 
CD200 were still decreased compared to control mice. Following full recovery from influenza 
infection, mice demonstrated intact cognitive function, and alterations in the hippocampal 
expression of cytokines, neurotrophic, and immunomodulatory factors were no longer evident. 
These findings suggest that while there are some relatively longstanding changes in 
hippocampal gene expression induced by influenza infection, neuroinflammation and cognitive 
dysfunction do not appear to persist following recovery from illness.  
 Collectively, these novel data indicate that peripheral infection with influenza virus elicits 
a central inflammatory response and impacts hippocampal structure and function. While there 
was no indication of prolonged cognitive dysfunction following recovery from illness, the 
heightened levels of inflammation concurrent with reduced neurotrophic support during acute 
sickness and continuing through the recovery period could leave the brain vulnerable to 
iv 
 
subsequent inflammatory insult. In addition, these findings are the first to demonstrate a 
possible role for environmental enrichment in reducing the negative consequences of influenza 
infection on the brain and behavior, and suggest that a more regulated neuroimmune response 
and/or maintenance of neurotrophic potential may underlie these neuroprotective effects.   
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CHAPTER 1 
GENERAL INTRODUCTION AND JUSTIFICATION 
 
The recent emergence of human transmissible, highly pathogenic avian (H5N1) and 
swine (novel H1N1) strains of influenza virus has raised international concern over the 
consequences of an impending global pandemic. Although much research effort has been 
focused on the development of antiviral drugs and effective vaccines, influenza viruses mutate 
rapidly and can quickly develop resistance to these therapeutic approaches (Carrat and 
Flahault, 2007). As eradication of the disease is highly unlikely, it is of crucial importance to gain 
a better understanding of the host response to this common viral pathogen. 
Neurological and cognitive effects associated with influenza infection have been 
reported throughout history (following the 1918 “Spanish” flu), as well as during the recent novel 
influenza A HIN1 pandemic, but the mechanisms underlying these symptoms remain unclear 
(Ravenholt and Foege, 1982; Studahl, 2003; CDC, 2009; Gonzalez-Duarte et al., 2010). Most 
influenza strains, including those responsible for pandemics, are considered non-neurotropic 
(Schlesinger et al., 1998; Kobasa et al., 2007; Wang et al., 2010), suggesting that neurological 
symptoms associated with influenza infection are not a result of direct viral invasion into brain 
regions relevant to behavior, but instead may be due to neuroinflammation induced by 
peripheral viral infection. While most people fully recover from influenza infection, it has been 
suggested that glia-mediated neuroinflammation in association with common respiratory viruses 
may lead to cumulative neuronal damage across the lifespan, and increase the risk for 
neurodegenerative disorders (Majde, 2010). 
While there is much evidence that immune signaling in the brain, and in particular 
inflammatory processes, can alter emotional and cognitive behaviors (Dantzer et al., 2008), the 
potential short and long-term consequences of peripheral influenza infection on central nervous 
system (CNS) function remain less well understood, and virtually unexplored. Therefore, the 
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goal of this research was to determine if infection with this common viral pathogen results in a 
central inflammatory response, alterations in neuronal structural plasticity, and cognitive 
dysfunction using a mouse model of influenza infection. Studies were focused on the impact of 
influenza infection on the structure and function of the hippocampus, as this is a brain region 
that exhibits a high degree of plasticity (Leuner and Gould, 2010), is vulnerable to 
neuroinflammation (Vitkovic et al., 2000; Lynch, 2002), and plays an important role in cognitive 
function (Bird and Burgess, 2008). 
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CHAPTER 2 
LITERATURE REVIEW 
 
 
2.1 Pathogenesis of Influenza Virus Infection 
Influenza viruses are enveloped single-strand RNA (ssRNA) viruses of the family 
Orthomyxoviridae and are classified into three distinct types, A, B, and C. Influenza type A 
viruses are the most virulent human pathogens and are responsible for the majority of yearly 
influenza epidemics (seasonal flu) and have the potential to cause severe pandemics (Reading 
et al., 2007). Influenza A viruses are classified into subtypes by their main surface 
glycoproteins, hemagglutinin (HA) and neuraminidase (NA). So far, 16 HA (H1-H16) and 9 NA 
(N1-N9) glycoproteins have been identified in influenza A viruses, but only 3 types of HA (H1, 
H2, H3) and 2 types of NA (N1, N2) are commonly found in humans (La Gruta et al., 2007; 
Subbarao and Joseph, 2007). Seasonal yearly epidemics are caused by variants of the 
subtypes H1N1 and H3N2 and kill about 1 million people per year world-wide (Fauci, 2006). 
Viral disease caused by influenza is a multifactorial disorder in which both virus-induced 
damage and host response to infection contribute to disease pathogenesis. Respiratory 
epithelial cells are the primary targets for influenza infection and replication, although recent 
evidence indicates macrophages, dendritic cells and natural killer cells can also be infected 
(Reading et al., 2007; Hao et al., 2008; Guo et al., 2009). Influenza infected cells produce 
different cytokines including proinflammatory cytokines (IL-1β, IL-6, IL-18, and TNF-α), antiviral 
cytokines (IFN-α, IFN-β, and IFN-γ), as well as chemokines  (RANTES, MIP, MCP-1, MCP-2 
and IP-10) which attract infiltrating cells, including neutrophils and T cells, to the site of infection 
(Julkunen et al., 2001; La Gruta et al., 2007). Events occurring comparatively late in the course 
of infection, such as development of cytotoxic T cells (CD8+ T cells) and helper T cells (CD4+ T 
cells), contribute to viral clearance and recovery through elimination of virus infected cells and 
promotion of specific antibody production (Doherty et al., 2006). While both innate and adaptive 
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immune responses are required for host protection and recovery from influenza infection, a 
delicate balance must be maintained in order to resolve the infection without tipping the balance 
in favor of the virus or into an overwhelming inflammatory response (Brydon et al., 2005). 
Although innate immune cells are essential in controlling early viral replication and regulating 
adaptive T and B cell responses, excessive production of inflammatory cytokines exacerbates 
clinical symptoms and contributes to potentially lethal lung pathology (La Gruta et al., 2007; 
McGill et al., 2009). 
Effective antiviral response including activation of the innate immune system and 
subsequent shaping of the adaptive immune response relies first on the ability of the host to 
detect influenza viral infection. Pattern recognition receptors (PRRs) expressed in innate 
immune cells as well as respiratory epithelial cells recognize viral associated molecules 
including genomic single stranded RNA (ssRNA) as well as double-stranded RNA (dsRNA) 
produced during viral replication (Kawai and Akira, 2006). Toll-like receptors (TLRs) and RNA 
helicase retinoic acid-inducible gene I (RIG-1) are the PRRs responsible for the recognition of 
influenza virus (Koyama et al., 2007; Wang et al., 2007) . Intracellular ssRNA activates TLR7 (in 
mouse) and TLR8 (in human), while TLR3 recognizes both intracellular dsRNA produced during 
viral replication as well as extracellular dsRNA released after the lysis of virally infected cells 
(Alexopoulou et al., 2001; Heil et al., 2004; Lund et al., 2004). Cytosolic receptor RIG-1 binds 
both viral ssRNA and dsRNA, thus providing an alternate pathway for influenza viral recognition 
(Yoneyama et al., 2004; Pichlmair et al., 2007). While these two classes of PRRs induce 
antiviral responses via different signaling pathways, they converge to activate transcription 
factors including interferon regulatory factors (IRFs) and nuclear factor kappa B (NFκB) which 
regulate the induction of Type I interferons and proinflammatory cytokines (Diebold et al., 2004; 
Le Goffic et al., 2007). 
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2.2 Mouse Model of Influenza Virus Infection 
The most common animal model for studying influenza infection is the mouse model 
using intranasal inoculation with mouse-adapted strain of human influenza A/PR/8/34 (H1N1) 
virus.  Mice develop a lower respiratory infection and exhibit clinical symptoms including 
anorexia, decreased locomotor activity, reduced food and water intake and hypothermia (Klein 
et al., 1992; Conn et al., 1995). Collectively these symptoms are standard of a typical sickness 
behavioral response and reflect adaptive physiological responses that promote recovery from 
infection (Dantzer, 2004). Several studies have documented an early rise in TNF-α, IL-1β, and 
IL-6 in the bronchoalveolar (BAL) fluids or lung homogenates in temporal association with 
symptom formation and lung pathology (Hennet et al., 1992; Conn et al., 1995; Peper and Van 
Campen, 1995). Recent evidence also suggests that in addition to the typical proinflammatory 
cytokines associated with sickness behavior, virally induced interferons (Type I IFN-α/β and 
Type II IFN-γ) also lead to symptoms fatigue and loss of body weight, as well as depressed 
locomotor activity and reduced food intake in mice (Crnic and Segall, 1992; Katafuchi et al., 
2003; Cunningham et al., 2007). Further insight into the contribution of specific proinflammatory 
cytokines during influenza comes from experiments using either specific cytokine antagonists or 
gene knockout mice (Van Reeth, 2000). It has been shown that injection of TNF-α antibodies at 
the time of influenza inoculation reduced lung pathology and prolonged survival in mice (Peper 
and Van Campen, 1995). In addition, treatment with naturally occurring IL-1 receptor antagonist 
(IL1-ra) produced a small but statistically significant increase in food intake and survival rates 
(Swiergiel et al., 1997). Finally, in knock-out mice deficient for either IL-1β or IL-6, influenza had 
less effect on body temperatures than in wild type mice, but depression in locomotor activity and 
body weight loss were unaffected (Kozak et al., 1995; Kozak et al., 1997). While these early 
studies confirmed the involvement of cytokines in influenza pathogenesis, the overall effect of 
blocking individual cytokines was both partial and modest. One plausible explanation for this is 
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the substantial redundancy between cytokines such as TNF-α, IL-1β and IL-6, in which the lack 
of one specific cytokine may be compensated for by another with overlapping activities.  
While the mouse model of influenza shows considerable similarities in both symptomatic 
and immune measures of human influenza infection several distinctions must be made. Mice 
are not naturally infected with influenza; therefore human influenza virus must be mouse-
adapted via serial passage in mouse lung. The mutant strains that emerge and cause disease in 
the mouse have a high replication efficiency in the lung and lead to development of viral 
pneumonia similar to that seen in severe human infections (Ward, 1997). In addition, standard 
inbred laboratory mice possess defective alleles of the Mx1 gene and thus do not possess a 
complete antiviral defense system (Staeheli et al., 1988). Interferon-induced  proteins such as 
Mx1, RnaseL and PKR (dsRNA-dependent protein kinase) have antiviral, antiproliferative and 
immunomodulatory functions and mice lacking some of these components show increased viral 
susceptibilities (Haller et al., 2007). The lack of biologically active Mx gene products that curb 
viral replication contributes to in increased pathogenesis and prolonged influenza replication in 
the lower respiratory tract (Grimm et al., 2007). In addition, unlike human infection, hypothermia, 
rather than fever, is usually observed in mice in response to challenge with influenza virus, 
regardless of the virus dose (Klein et al., 1992; Conn et al., 1995). Hypothermia, like fever, is 
mediated by cytokines such as TNF-α, IL-1β and interferons, and is considered an adaptive 
response in small mammals used to conserve energy reserves (Leon, 2004; Romanovsky et al., 
2005). In rodents, regulated hypothermia enhances survival and influenza infected mice forced 
to warm to normal body temperatures (and raise their metabolic rate) die in large numbers 
(Klein et al., 1992).  
 
2.3 Immune-Brain Communication 
The bi-directional communication between the immune system and central nervous 
system (CNS) is critical for mounting an appropriate immunological, physiological and 
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behavioral response to infection and injury. The host’s first line of defense is the innate immune 
system. Innate immune cells, including macrophages in the periphery, and microglial cells in the 
CNS, detect potential insults via pattern-recognition receptors (PRRs) which recognize and 
respond to infectious elements (pathogen-associated molecular patterns, PAMPs), as well as 
endogenous danger signals induced by tissue damage (danger-associated molecular patterns, 
DAMPs) (Matzinger, 2002; Akira et al., 2006). Upon activation, cells of the innate immune 
system synthesize and release cytokines such as interleukin (IL)-1β, IL-6 and tumor necrosis 
factor-α (TNF-α) that serve as major mediators of the immune response. 
Peripheral cytokines induced by the innate immune system act on the brain to induce 
nonspecific symptoms of infection including lethargy, listlessness, decreased activity and loss of 
interest in social interaction (Kelley et al., 2003). This aspect of host defense has been termed 
the “sickness response” and includes changes in body temperature, increased sleep, reduction 
in food and water intake, and activation of the hypothalamic-pituitary-adrenal (HPA) axis (Maier 
and Watkins, 1998; Dantzer and Kelley, 2007). The physiological and behavioral aspects of the 
sickness response reflect the expression of an adaptive motivational state that resets the 
organism’s priorities to promote resistance to pathogens and recovery from infection (Hart, 
1988; Dantzer, 2001; Johnson, 2002).  To induce a behavioral response, peripheral cytokines 
need to be able to exert their effects in the brain. Cytokines can access the brain via active 
transport mechanisms or diffusion at circumventricular organs (CVOs) where blood vessels lack 
a functional blood-brain barrier (Konsman et al., 1999; Banks et al., 2002). In addition, 
peripheral cytokines do not need to gain direct entry into the CNS because they can act at the 
blood-brain barrier to induce the synthesis and release of inflammatory mediators (cytokines 
and prostaglandins) from brain endothelial cells which then propagate the immune signal within 
the brain (Wong and Licinio, 1994; Vitkovic et al., 2000). Finally, neural pathways (via the 
afferent vagus nerve)  are directly responsive to peripheral cytokine stimulation, the signal then 
being transmitted to the CNS where it activates central effects including cytokine expression 
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and sickness behavior (Goehler et al., 1998; Luheshi GN, 2000).  When cytokine signals from 
the peripheral immune system reach the CNS, microglia become activated and propagate the 
inflammatory response throughout the brain. 
 
2.4 Microglial Activation 
Microglial cells comprise approximately 10-12% of the cells in the brain and predominate 
in the grey matter, with especially high concentrations in the hippocampus, hypothalamus, basal 
ganglia and substantia nigra (Lawson et al., 1990; Mittelbronn et al., 2001; Block et al., 2007). 
Microglia normally exist in a quiescent or “resting” state in the healthy adult brain and are 
morphologically characterized by a small soma and long, thin (ramified) processes (Hanisch and 
Kettenmann, 2007). Although termed “resting”, microglia in the intact adult brain are not 
dormant. Highly motile microglial processes continuously scan the CNS microenvironment with 
estimates that the complete brain parenchyma is monitored every few hours (Davalos et al., 
2005; Nimmerjahn et al., 2005). Even minor alterations in the CNS homeostasis alert microglia, 
allowing these cells to provide the first line of defense during infection, injury and disease. 
In response to inflammatory stimuli, microglia are rapidly activated and undergo a 
morphological transformation with shorter, stouter processes (i.e.deramified) and larger soma 
size (Long et al., 1998; Hanisch, 2002; Hanisch and Kettenmann, 2007). In addition, microglia 
upregulate cell surface molecules including major histocampatibility markers (MHC class I and 
II), receptors for cytokines and chemokines, and several other cellular markers indicative of 
increased reactivity (Perry and Gordon, 1988; Lynch, 2009). In response to a variety of stimuli, 
microglia can transform from a quiescent state to different activation states. The magnitude of 
microglial activation is influenced by the type and duration of the stimulus, the current CNS 
microenvironment and exposure to prior and existing stimuli (Schwartz et al., 2006; Perry et al., 
2007; Ransohoff and Perry, 2009). Activated microglia release immune mediators that 
coordinate the response of both innate and adaptive immunity to control infection, remove cell 
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debris and promote tissue repair (Kreutzberg, 1996; Streit, 2002; Neumann et al., 2009). 
Although microglial activation is necessary for host defense and neuroprotection, increased or 
prolonged activation can have detrimental and neurotoxic effects (Block et al., 2007).   
 
2.5 Inflammation and Cognition 
Since the sickness response also entails confusion and the inability to concentrate, it is 
thought that there is also an arousal and cognition component involved. Experimental evidence 
has shown that cytokines administered both centrally and peripherally can act on the central 
nervous system (CNS) to induce changes in learning and memory in both humans and animals 
(Gibertini, 1998; Wilson et al., 2002). Although differing in degree of expression, neurons and 
glia constitutively express proinflammatory cytokines, suggesting they play a role in normal 
neuronal functioning in addition to acting as inflammatory mediators (Vitkovic et al., 2000). 
Furthermore, experimental data show that the receptors for inflammatory cytokines such as IL-
1β and TNF-α are constitutively expressed on neurons and glial cells in the normal brain, 
rendering these cells sensitive to even very low levels of cytokines (Vitkovic et al., 2000; Parnet 
et al., 2002).  In the rodent brain, the highest densities of receptors for IL-1β, IL-2, IL-6 and TNF-
α have been localized to the hippocampus, suggesting a role of proinflammatory cytokines in 
hippocampal functions such as learning and memory (Ban et al., 1991; Ericsson et al., 1995; 
Vitkovic et al., 2000; Wilson et al., 2002; Dantzer, 2004). IL-1β can act directly on neurons in the 
hippocampus to impair long-term potentiation (LTP), and the increase in endogenous IL-1β 
concentration in the dentate gyrus, that occurs with age, is inversely proportional to facilitation of 
LTP (Murray and Lynch, 1998; Lynch, 2002). Studies have shown that IL-1β administered 
peripherally or induced by peripheral immune stimuli, such as infection or lipopolysaccharide 
(LPS), impairs performance in several hippocampal-dependent tests including the spatial 
version of the Morris water maze and contextual fear conditioning (Aubert et al., 1995; Gibertini, 
1998; Pugh et al., 1998). In addition to the effects of acute inflammation on memory function, it 
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has also been shown that chronic elevation of IL-1β in the hippocampus produces deficits in 
spatial memory in the Y-maze that can be ameliorated by infusion of IL-1β receptor antagonist 
(IL-1ra) (Palin et al., 2004). IL-1β induced memory impairment appears to be specific to learning 
and memory processes that are hippocampal-dependent whereas hippocampal-independent 
memories are not affected (Gibertini, 1996; Rachal Pugh et al., 2001; Goshen, 2007).  
Although IL-1β mediated disruption of cognitive function is most extensively studied, 
evidence also supports a role for both TNF-α and IL-6 in hippocampal-dependent learning and 
memory deficits as well as disrupted hippocampal plasticity (Fiore et al., 2000; Balschun et al., 
2004; Pickering and O'Connor, 2007). In addition, IL-6 knockout mice are protected from LPS-
induced disruption in learning and memory due to markedly attenuated hippocampal expression 
of IL-1β and TNF-α (Sparkman et al., 2006).  While basal levels of TNF-α are thought to play a 
role in synaptic plasticity, high levels can induce glutamate excitotoxicity and have been shown 
to play a role neurodegeneration (Perry et al., 2001; Stellwagen and Malenka, 2006; Takeuchi 
et al., 2006).  
While it is clear that cytokines induced by LPS, and in particular IL-1β, can impair 
learning and memory, less is known regarding the cognitive effects of virally induced interferons. 
Interferon therapy in humans produces flu-like symptoms and adverse neuropsychological 
effects including confusion, anxiety, memory alterations and depression (Smith et al., 1988; 
Valentine et al., 1998; Capuron et al., 2001). It has also been shown that IFN-α induces 
cognitive dysfunction in animals and over-expression leads to neuroinflammation and 
neurodegeneration (Paul et al., 2007; Sas et al., 2009). Little is known about the neurological 
effects of IFN-β, although it has been shown to upregulate IL-6 production in astrocytes and 
alter proteins involved in neuroplasticity, suggesting it may serve a more modulatory than direct 
role in inflammation related dysfunction (Okada et al., 2005; Beyer et al., 2009). In the central 
nervous system, IFN-γ can be produced by resident cells including microglia, astrocytes and 
neurons in response to infection or other pathogenic stimuli (Benveniste, 1998; Mastrangelo et 
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al., 2009). In addition, IFN-γ is known to upregulate microglial expression of MHCII and has 
been shown to inhibit LTP in the hippocampus when administered intracerebrally (Neumann, 
2001; Maher et al., 2006). Most studies suggest that unlike sickness behavior, there is no real 
adaptive purpose for these cognitive impairments and that cytokine-mediated deficits in 
cognition may be a significant negative side effect of the inflammatory response (Maier and 
Watkins, 1998).  
 
2.6 Inflammation and Neuroplasticity 
The hippocampus has been shown to be involved in cognitive processes including 
learning and memory and is considerably plastic at both the physiological and structural level 
(Neves et al., 2008). Dendritic spines are the postsynaptic site for most excitatory glutamatergic 
synapses, and the number of spines is considered an estimate of synaptic inputs a neuron 
receives (Spruston, 2008). As such, changes in neuronal architecture and spine density can 
affect synaptic plasticity which is generally believed to underlie hippocampal-dependent learning 
and memory (Bliss and Collingridge, 1993; Segal, 2005). In addition to impairments in LTP, 
reductions in neuronal branching complexity, as well as decreased spine density, are thought to 
underlie inflammation-induced cognitive dysfunction.  
Evidence for cytokine induced dendritic atrophy comes from both in vitro and in vivo 
studies. In neuron culture, supernatant from LPS-activated microglia prevented neurite 
outgrowth and TNF-α was shown to induce the retraction of already extended dendrites 
(Neumann et al., 2002; Munch et al., 2003). In mice injected centrally with LPS, there was 
significant degeneration of spines and reduced dendritic branching in hippocampal pyramidal 
neurons without a corresponding loss of neuron number (Milatovic et al., 2003). These results 
demonstrate that even in highly inflammatory conditions, cell death does not normally occur 
suggesting that changes in behavior are likely due to altered neuronal structure. In addition, 
data from our lab has shown that aged mice injected peripherally with LPS have an exaggerated 
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neuroinflammatory response that is accompanied by impaired cognitive function and atrophy of 
neurons in the hippocampus (Richwine et al., 2008). While most studies have focused on 
changes in neuron morphology following LPS challenge, it has also been shown, at least in cell 
culture, that IFN-γ can inhibit dendritic growth and trigger dendritic retraction in neurons without 
compromising cell viability or altering axonal morphology (Kim et al., 2002; Andres et al., 2008).  
An additional mechanism by which inflammatory stimuli can lead to alterations in 
hippocampal structure and function is by inhibiting neurotrophic factors. The neurotrophin family 
of growth factors include nerve-growth factor (NGF), brain-derived neurotropic factor (BDNF), 
neurotrophin-3 (NT3) and neurotropin-4 (NT4). Neurotrophins have been shown to regulate 
neuronal structure and function by modulating axon and dendrite morphology, synaptic 
plasticity, and memory formation (McAllister et al., 1999; Poo, 2001; Tyler et al., 2002; Chao, 
2003). In conditions shown to increase dendritic complexity and enhance cognition, including 
environmental enrichment and physical activity, levels of BDNF and NGF are increased in the 
hippocampus and cortex (Neeper et al., 1996; Pham et al., 2002; Branchi et al., 2006).  On the 
other hand, dysregulated or reduced expression of BDNF is associated with exposure to chronic 
stress, during normal aging, and in neuropathological states including Alzheimer’s disease, 
schizophrenia, and depression (Smith et al., 1995; Angelucci et al., 2005; Tapia-Arancibia et al., 
2008). Interestingly, not only are these states associated with changes in neuron structure and 
function and deficits in cognition, but also demonstrate a neuroinflammatory component 
(Dantzer et al., 2008; Godbout and Johnson, 2009). 
The association amongst increased inflammatory factors and reduced neurotrophins is 
not just correlational, as it has been shown in neuron culture that IL-1β directly interferes with 
both BDNF and NT3 signaling pathways by reducing activation of the docking proteins needed 
to convey receptor activation cascades (Soiampornkul et al., 2008; Tong et al., 2008).  
Furthermore, in vivo work has shown that rats injected intrahippocampally with IL-1β 
demonstrated reduced BDNF expression in the CA1 and dentate gyrus and impaired 
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hippocampal-dependent memory (Barrientos et al., 2004). Additional studies have shown that 
peripheral immune activation also reduces neurotrophic factors in the hippocampus of both 
adult and aged mice (Richwine et al., 2008; Chapman et al., 2011), with evidence of significantly 
reduced levels of BDNF, NGF, and NT-3 in the hippocampus and cortex for 7 days following 
peripheral LPS injection (Guan and Fang, 2006). It is likely that during infection, 
proinflammatory cytokines disrupt neuronal functions that are normally maintained by 
neurotrophins, thus leaving the brain vulnerable to the detrimental effects of neuroinflammation. 
 
2.7 Neuron-Microglia Interactions 
One proposed mechanism for maintaining control of microglial activation is through 
interaction with neuronal signaling molecules. Healthy neurons maintain microglia in their 
resting state via secreted and membrane bound signals including CD200, CX3CL1 (fractalkine), 
neurotransmitters and neurotrophins (Biber et al., 2007; Pocock and Kettenmann, 2007). A 
reduction in these regulatory factors can lead to a reactive microglia phenotype, suggesting an 
important role for communication between neurons and microglia in regulating 
neuroinflammation. During normal conditions, such signals efficiently regulate neuroimmune 
responses and help return the CNS microenvironment to a homeostatic state following insult. 
However, these neuromodulatory mechanisms may become deficient and/or dysregulated 
under excessive or prolonged inflammatory stimulation induced by disease and injury.  
Microglia phenotype and function is highly influenced by the conditions of the CNS 
microenvironment and in particular, by specific interactions with surrounding neurons. While 
intense focus has been given to glial cell involvement in neuroinflammatory processes, the roles 
of neurons have been less examined, or even relegated to that of passive victims of overactive 
microglia. However, mechanisms of immune regulation in the CNS are largely dependent on 
neuronal viability and activity, providing compelling evidence that neurons themselves control 
microglial reactivity (Biber et al., 2007; Tian et al., 2009). 
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Fractalkine 
Recent work has shown that the neuronally expressed chemokine, fractalkine, may be 
important in maintaining microglia in a resting state in the healthy brain as well as preventing 
excessive microglial activation during inflammatory conditions. Fractalkine (CX3CL1) is the sole 
member of the CXC subfamily of chemokines and exists as both a membrane-anchored ligand 
and a secreted glycoprotein suggesting that it can work locally, by direct contact, as well as 
through distant soluble effects (Bazan et al., 1997). Fractalkine is one of a few chemokines that 
is constitutively expressed at high levels in the brain and is unique in that it binds only one 
receptor, CX3CR1 (Pan et al., 1997; Harrison et al., 1998). The widespread expression of 
fractalkine by neurons in the CNS along with complementary expression of its receptor on 
microglia, suggests that fractalkine plays an important physiological role in the communication 
between neurons and microglia (Harrison et al., 1998; Cardona et al., 2006).  
Evidence from both in vitro and in vivo experiments demonstrates that interaction of 
fractalkine and its receptor contribute to attenuation of microglial activation and neurotoxicity 
under inflammatory conditions. In vitro, soluble fractalkine acts as an anti-inflammatory molecule 
via down-regulation of LPS-induced production of IL-1β, IL-6, TNF-α, nitric oxide and iNOS in 
microglia and mixed glia cultures (Zujovic et al., 2000; Mizuno et al., 2003). Recent work has 
shown that both soluble and neuron-membrane bound fractalkine attenuate the LPS-induced 
increase in IL-1β and MHCII in primary microglial-neuronal cultures (Lyons et al., 2009). The 
addition of anti-fractalkine receptor antibody abrogates this effect indicating the CX3CL1-
CX3CR1 interaction is necessary for modulation of microglial activation. In vivo, blocking 
endogenous fractalkine within the brain using an anti-fractalkine antibody potentiates the LPS-
induced increase in hippocampal expression of TNF-α and 8-isoprostane (a marker of oxidative 
stress), suggesting that normal expression of fractalkine is necessary to control microglial 
activation (Zujovic et al., 2001).  
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Using mice lacking the microglial fractalkine receptor, it has been shown that the 
absence of CX3CL1-CX3CR1 signaling dysregulates microglial responses to both inflammatory 
and neurotoxic stimuli. CX3CR1-deficient mice show intense and widespread microglial 
activation as well as elevated production of IL-1β in the hippocampus in response to peripheral 
LPS injection (Cardona et al., 2006)... In addition, in mouse models of Parkinson’s disease and 
amyotrophic lateral sclerosis (ALS), CX3CR1-deficient mice had more pronounced microglial 
activation and extensive neuronal loss compared to wild-type controls (Cardona et al., 2006). 
Overall these data suggest that during both acute inflammation and chronic neurodegeneration, 
CX3CL1-CX3CR1 interactions in the CNS function to attenuate excessive microglial activation. 
While well-known for its role in immune function, recent evidence suggests that disruption of 
CX3CL1 signaling can inhibit neurogenesis (Bachstetter et al., 2011), impair microglia-mediated 
synaptic pruning in the hippocampus (Paolicelli et al., 2011), and prevent the enhancement of 
neuronal plasticity and spatial cognition induced by environmental enrichment (Maggi et al., 
2011), suggesting it may play an important role in hippocampal function. 
 
CD200  
Another factor known to play a role in modulating immune responses is the membrane 
glycoprotein CD200. CD200 is expressed on a wide variety of cell types including neurons and 
endothelial cells in the CNS whereas expression of its receptor, CD200R, is restricted 
predominantly to cells of myeloid origin including macrophages and microglia (Hoek et al., 2000; 
Barclay et al., 2002; Wright et al., 2003). It has been suggested that interaction between 
neuronal CD200 and microglia-bound CD200R maintain microglia in a quiescent state (Hoek et 
al., 2000; Neumann, 2001). Microglia of CD200-deficient mice spontaneously exhibit a more 
reactive phenotype, including less ramified and shorter processes, and increased expression of 
CD11b and CD45, suggesting that constitutive interaction between CD200 and CD200R plays 
an important role in maintaining microglia in a resting state (Hoek et al., 2000). Several studies 
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have demonstrated that disruption of the CD200-CD200R interaction results in exaggerated and 
prolonged microglia activation and increased production of inflammatory mediators following 
immune challenge (Hoek et al., 2000; Wright et al., 2003; Deckert et al., 2006; Meuth et al., 
2008) 
In addition to its physiological role of maintaining microglia in a quiescent state in the 
intact CNS, CD200 may also play a neuroprotective role in chronic neurodegenerative diseases. 
While lack of CD200 signaling exacerbates neuroinflammation, enhanced CD200-CD200R 
signaling either via increased neuronal expression of CD200 or administration of the CD200R 
agonist CD200-Fc fusion protein, can down-regulate microglia activation, reduce pro-
inflammatory cytokine expression and maintain neuronal integrity in the rodent experimental 
autoimmune encephalomyelitis (EAE) model of multiple sclerosis (MS) (Chitnis et al., 2007; Liu 
et al., 2010). Recent findings in human patients also support the role of CD200 in regulating 
microglia activation in neuropathological conditions. Expression of CD200 has been found to be 
downregulated in lesions from the CNS of MS patients suggesting that the loss of CD200 
permits enhanced inflammation, which may drive disease progression (Koning et al., 2007; 
Koning et al., 2009). Examination of postmortem brain tissue from Alzheimer’s disease patients 
found that both CD200 and CD200R are significantly decreased in regions affected by AD 
pathology (hippocampus and inferior temporal gyrus) indicating an overall deficiency in the 
CD200-CD200R signaling system in regions where chronic inflammation is established (Walker 
et al., 2009). While it is known that CD200 is important for keeping microglia in a resting state in 
both the healthy and diseased brain (Hoek et al., 2000; Chitnis et al., 2007), recent evidence 
suggests that constitutive expression of CD200 is essential for normal hippocampal plasticity 
and resiliency from inflammatory stimuli (Costello et al., 2011). In addition, it was recently shown 
that hippocampal dendrites express high levels of CD200, suggesting a role for this immune 
mediator in glial-synaptic interactions (Ojo et al., 2011). 
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Similar to the CD200-CD200R interaction, the constitutive expression of CD47 and 
CD22 on neurons is also thought to play a role in keeping microglia quiescent via interaction 
with microglial receptors SIRP-α and CD45. (Barclay et al., 2002; Mott et al., 2004; Biber et al., 
2007; Tian et al., 2009). Neurons can also secrete CD22 which acts as an anti-inflammatory 
neuropeptide, reducing LPS-induced microglial activation and pro-inflammatory cytokine 
production (Mott et al., 2004). In this study it was demonstrated that neurons must have 
functional axon terminals for this inhibition to occur, suggesting that physiologically intact 
neurons are necessary for the regulation of microglial activation. 
 
Neuronal Integrity 
In addition to controlling microglial activity via immunomodulatory factors, the normal 
physiological activity of neurons is a key negative regulator of the CNS immune response. 
Functionally active neurons release a number of soluble mediators including neurotransmitters 
and neurotrophic factors that keep microglia in a resting state (Neumann, 2001; Pocock and 
Kettenmann, 2007). Even relatively minor deviations from normal neuronal activity seem to be 
sufficient to alert microglia, which express several neurotransmitter and neurotrophic factors 
allowing for response to alterations in the neuronal network integrity (Schwartz et al., 2006; 
Hanisch and Kettenmann, 2007; Pocock and Kettenmann, 2007). Control of microglial reactivity 
by healthy functional neurons was demonstrated in hippocampal slice culture in which blockade 
of spontaneous neuronal activity resulted in increased microglial expression of MHCII 
(Neumann et al., 1996).  It was further demonstrated that brain-derived neurotrophic factor 
(BDNF), nerve-growth factor (NGF) and neurotrophin-3 (NT-3) secreted by electrically active 
neurons can inhibit the induction of MCHII expression in microglia (Neumann et al., 1998). 
If healthy functional neurons have a generally suppressive potential that helps to 
maintain microglia in a resting state, then it follows that the loss of physiological activity due to 
impaired function or atrophy of neurons could contribute to increased microglial activation and 
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inflammation. In several states including exposure to chronic stress, normal aging, and in 
neuropathologies including Alzheimer’s disease, schizophrenia and depression, there is a 
demonstrated neuroinflammatory component along with reduced neurotrophic support, and 
evidence of neuronal atrophy (Smith et al., 1995; Angelucci et al., 2005; Godbout and Johnson, 
2006; Dantzer et al., 2008; Tapia-Arancibia et al., 2008; Lupien et al., 2009). A reduction in 
normal neuronal function could allow microglia to escape regulatory control leading to excessive 
microglial activation and increased inflammation-induced neuronal damage (Figure 2.1). 
Prolonged or aberrant microglial activation may not be restricted to gain of inflammatory 
function, but may also include the loss of neuronal support and protection. Microglia perform 
important and necessary physiological functions including monitoring and maintaining the 
functional state of neuronal synapses, supporting neurogenesis and clearing tissue debris to 
facilitate regeneration (Ziv and Schwartz, 2008; Napoli and Neumann, 2009; Wake et al., 2009; 
Tremblay et al., 2011). Together these data suggest that the bi-directional communication 
between neurons and microglia plays an important role in maintaining CNS homeostasis. 
Therefore, any prolonged alteration in the normal function of either of these populations could 
contribute to dysregulation of the neuroimmune response and leave the brain vulnerable to the 
detrimental effects of neuroinflammation. 
 
2.8 Environmental Enrichment and Neuroplasticity 
A potential strategy for increasing brain plasticity and resiliency is environmental 
enrichment.  Environmental enrichment (EE) is classically defined as a “complex combination of 
social and inanimate stimulation” (Rosenzweig and Bennett, 1996) in comparison to standard 
housing conditions. While there is variation in experimental protocols (Simpson and Kelly, 
2011),  in general EE refers to conditions that provide increased social, cognitive and physical 
stimulation, and typically includes group housing in a large cage with nesting materials, various 
toys, tunnels and ladders for exploration, and running wheels for voluntary exercise (van Praag 
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et al., 2000; Nithianantharajah and Hannan, 2006). Items of enrichment are routinely changed 
during the experimental period to maintain novelty and provide continuous opportunity for 
exploration and learning.  
Environmental enrichment has been shown to exert positive effects on cognitive and 
emotional behaviors including enhanced learning and memory (Nilsson et al., 1999; Bruel-
Jungerman et al., 2005; Leggio et al., 2005), and improved ability to cope with fear, anxiety and 
stress (Larsson et al., 2002; Fox et al., 2006; Schloesser et al., 2010). Early work demonstrated 
that exposure to a complex and stimulating environment could produce changes in neuron 
morphology, myelination and synaptogenesis during development through old age, suggesting 
that neural plasticity in response to environmental experience exists throughout the lifespan 
(Bennett et al., 1969; Volkmar and Greenoug.Wt, 1972; Diamond et al., 1976; Green et al., 
1983; Greenough et al., 1986; Juraska and Kopcik, 1988). In addition to morphological changes, 
EE has also been shown to elevate levels of neurotrophic factors (Pham et al., 1999; Ickes et 
al., 2000) and synaptic proteins (Rampon et al., 2000; Nithianantharajah et al., 2004), as well as 
enhance hippocampal synaptic plasticity (Green and Greenough, 1986; Artola et al., 2006) and 
increase neurogenesis (Kempermann et al., 1997; Rossi et al., 2006).   
Studies aimed at separating out the contributions of particular components of 
environmental enrichment (social, sensorimotor, physical, cognitive), have shown that each can 
exert positive effects on the brain and behavior (Johansson and Ohlsson, 1996; Cracchiolo et 
al., 2007; Madronal et al., 2010).  Physical exercise in particular has been shown to enhance 
neuroplasticity, improve cognition, and serve as a potent stimulus for increased neurogenesis 
(Cotman et al., 2007; van Praag, 2009). While it is important to examine the unique, as well as 
overlapping neurobiological consequences of the various components of enrichment, there is 
much evidence to suggest that the greatest benefits come from additive or synergistic effects of 
the full repertoire of environmental enrichment (Faherty et al., 2003; Will et al., 2004; Leggio et 
al., 2005; Sozda et al., 2010). In addition, the increased complexity afforded by the 
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simultaneous exposure to all aspects of enrichment may better recapitulate the mentally and 
physically active lifestyle that has been shown to be associated with increased brain and 
cognitive reserve. The theory of brain and cognitive reserve suggests/posits that neurobiological 
changes induced by a physically and mentally active lifestyle (modeled by EE in animal 
models), promotes brain resiliency through more efficient and flexible networks that are less 
susceptible to disruption induced by injury or neurodegeneration (Petrosini et al., 2009). While 
first described in terms of Alzheimer’s and dementia (Mortimer, 1997; Stern et al., 2003; 
Fratiglioni and Wang, 2007), neuroprotective and compensatory mechanisms induced by 
modulation of the environment have been shown to increase the (brain’s) ability of the brain to 
cope with a variety of neurological insults (Nithianantharajah and Hannan, 2009). 
 
2.9 Environmental Enrichment and the Neuroimmune Response 
In addition to the beneficial effects  of EE in in normal intact healthy animals, the 
influence of EE on CNS structure and function has been explored during aging, as well as in 
animal models of neurodegenerative disease, psychiatric disorders, and brain injury (Will et al., 
2004; Nithianantharajah and Hannan, 2006; Mora et al., 2007; Laviola et al., 2008). While the 
beneficial effects of environmental enrichment have primarily focused on changes in neuron 
morphology, synaptic plasticity, and neurogenesis, EE also induces changes in non-neuronal 
components including cerebrovasculature, oligodendrocytes, and astrocytes (Soffie et al., 1999; 
Markham and Greenough, 2004; Ekstrand et al., 2008; Viola et al., 2009) suggesting the 
potential for modulation of neuron-glia interactions. While less is known regarding the direct 
effects of EE on microglia, evidence suggests that they are also responsive to physical and 
cognitive stimulation. In healthy mice exercise has been shown to induce proliferation of cortical 
microglia that displayed a ramified morphology indicative of a resting state (Ehninger and 
Kempermann, 2003). In addition, it was also shown that environmental enrichment of adult rats 
increased numbers of microglia in the dentate gyrus that displayed a phenotype associated with 
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neuroprotection and enhanced neurogenesis (Ziv et al., 2006).  Together, these data suggest 
that increased activity and enrichment can induce proliferation of microglia that appear to have a 
beneficial and/or protective phenotype in the normal brain.  
Environmental enrichment has also been shown to influence the central immune system 
in response to neurodegeneration and brain damage. In two different mouse models of 
Alzheimer’s disease, environmental enrichment was shown to shift microglia from a neurotoxic 
to phagocytic phenotype that was associated with less amyloid burden, reduced inflammation, 
upregulation of anti-inflammatory factors, and improvements in learning and memory (Ambree 
et al., 2006; Dong et al., 2007; Herring et al., 2010). In addition, long-term housing in EE 
following traumatic brain injury reduced inflammatory cytokines and astrogliosis in the 
hippocampus, and improved spatial learning (Kovesdi et al., 2011), while short-term exposure 
following stroke improved recovery of neurological function and reduced astrocyte reactivity and 
IL-1β expression in the infarct area (Ruscher et al., 2009).  In both models, the reduction of 
inflammatory cytokines and astrogliosis was paralleled by restoration of behavioral function, 
suggesting a reparative role of EE during injury-induced neuroinflammation. Collectively, these 
findings suggest that environmental enrichment can influenza the neuroimmune response to 
promote a microenvironment associated with reduced inflammation and increased 
neuroprotection during injury and degeneration. It is possible the EE helps modulate the 
reactive state of microglia to maintain homeostasis during injury and disease. In some cases EE 
can induce “beneficial” microglia activation associated with neurogenic or phagocytic processes, 
while in other circumstances, the attenuation of aberrant or prolonged microglial activation can 
prevent neuroinflammatory damage.  
In contrast to the many studies investigating the effects of EE in a variety of 
neuropathological and neuropsychiatric diseases, there is very little data concerning the impact 
EE may have on the brain during infectious disease. Previous work has shown that in normal 
healthy mice, environmental enrichment enhanced NK cell activity (Benaroya-Milshtein et al., 
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2004), and altered the percentage of CD4+ and CD8+ T cells (Marashi et al., 2004) in the 
spleen of healthy adult mice without appreciable effects on the levels of IFN-y, IL-2, IL-10 and 
IL-4 (Marashi et al., 2003). In terms of EE altering the immune response to peripheral immune 
challenge, the data are mixed, with findings that EE reduced sickness behavior in response to 
LPS (Mlynarik et al., 2004; Kentner et al., 2008), EE had no effect during chronic mycobacterial 
infection as assessed by changes in immune cell population, bacterial load and serum interferon 
levels (Olsson et al., 2010), and EE reduced resistance to parasitic infection (Barnard et al., 
1996). In terms of the central immune response, one study found there to be no benefit of EE on 
neurogenesis or spatial learning when implemented after infection with bacterial meningitis 
(Tauber et al., 2009), while another study found mice reared in EE to have less viral 
neuroinvasion, reduced microglial activation, and improved behavioral outcomes in a model of 
neurotropic viral encephalitis (de Sousa et al., 2011).  While these studies have investigated the 
effects of EE in models of direct CNS infection, as of yet, there are no data concerning the 
impact of environmental enrichment on the central immune response and cognitive behavior 
during peripheral viral infection. 
  
2.10 Summary and Objectives 
In summary, influenza infection remains a significant health concern and economic 
burden around the world.  In the U.S. alone, the seasonal flu infects millions of people each 
year, resulting in more than 200,000 hospitalizations and 36,000 deaths (CDC, 2009). While 
there are reports of neurological sequelae following influenza infection, the mechanisms 
regarding how non-neurotropic viral strains impact brain function remain largely unknown 
(Studahl, 2003). 
As evidenced by the background information, the abundance of research investigating 
the effects of peripheral infection on the central immune response, and consequent influence on 
behavior, have used LPS (which mimics a bacterial infection) to activate the innate immune 
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system. There is considerably less data concerning the effects of peripheral viral infection on 
cognitive function, although studies using day-old chicks (Kent et al., 2007), and a novel piglet 
model (Dilger and Johnson, 2010),  have shown the viral mimetic Poly I:C to induce learning 
and memory deficits. As of yet, there are no studies determining the effects of peripheral viral 
infection on hippocampal function or cognitive behavior in adult mice. Moreover, in studies using 
either LPS or Poly I:C, the immune and behavioral effects are extremely short-lived and animals 
recover in a matter of 2-24 hours. Infection with influenza provides a model to study the short 
and long-term effects of the central immune response to a clinically relevant human pathogen 
over the course of weeks instead of hours. 
This dissertation was designed to investigate if peripheral infection with live influenza 
virus leads to neuroinflammation and cognitive dysfunction, and further, whether these effects 
are associated with increased microglial activation and changes in neuron morphology. In 
addition, the potential for environmental enrichment to ameliorate the impact of influenza 
infection on the brain was investigated, as this paradigm has been shown to exert a plethora of 
beneficial effects on CNS structure and function, but its application during peripheral infection 
remains unexplored.  
These experiments are important because they use a clinically relevant, highly 
contagious ,and common human pathogen to fill a void in our understanding of how peripheral 
viral infection can impact the structure and function of the central nervous system. In particular, 
as it has been suggested that repeated infection with common respiratory viruses may increase 
neuronal vulnerability to degeneration (Majde, 2010), a better understanding of how influenza 
impacts the brain and behavior may provide insight for preventing inflammation and neuronal 
damage during peripheral viral infection. 
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2.11 Figure 
 
Figure 2.1 Excessive or prolonged inflammation resulting from increased microglial activation 
could contribute to neuronal damage and the loss of neuroregulatory/neuroprotective factors 
(BDNF, NGF, CD200, CX3CL1). In turn, damaged  neurons would  no longer adequately control 
microglial reactivity, thus resulting in (over time) a vicious cycle of neuroinflammation and loss of 
neuronal integrity that could lead to neurobehavioral impairment. 
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CHAPTER 3 
INFLUENZA INFECTION INDUCES NEUROINFLAMMATION AND IMPACTS 
HIPPOCAMPAL NEURON MORPHOLOGY AND COGNITION IN ADULT MICE 
 
3.1 Abstract  
   
Influenza is a common and highly contagious viral pathogen yet its effects on the 
structure and function of the central nervous system remain largely unknown. Although there is 
evidence that influenza strains that infect the brain can lead to altered cognitive and emotional 
behaviors, it is unknown if a viral strain that is not neurotropic (A/PR/8/34) can result in a central 
inflammatory response, neuronal damage and neurobehavioral effects. We hypothesized that 
neuroinflammation and alterations in hippocampal neuron morphology may parallel cognitive 
dysfunction following peripheral infection with live influenza virus. Here we show that influenza-
infected mice exhibited cognitive deficits in a reversal learning version of the Morris water maze. 
At the same timepoint in which cognitive impairment was evident, proinflammatory cytokines (IL-
1β, IL-6, TNF-α, IFN-α) and microglial reactivity were increased, while neurotrophic (BDNF, 
NGF) and immunomodulatory (CD200, CX3CL1) factors were decreased in the hippocampus of 
infected mice. In addition, influenza induced architectural changes to hippocampal neurons in 
both the CA1 and dentate gyrus, with the most profound effects on dentate granule cells in the 
innermost portion of the granule cell layer. Overall these data provide the first evidence that 
neuroinflammation and changes in hippocampal structural plasticity may underlie cognitive 
dysfunction associated with influenza infection. In addition, the heightened inflammatory state 
concurrent with reduced neurotrophic support could leave the brain vulnerable to subsequent 
insult following influenza infection. A better understanding of how influenza impacts the brain 
and behavior may provide insight for preventing inflammation and neuronal damage during 
peripheral viral infection. 
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3.2 Introduction 
Influenza remains a leading cause of illness and death throughout the world, making it a 
serious health concern as well as a significant economic burden. While most people fully 
recover from influenza infection, the potential short and long-term consequences on central 
nervous system (CNS) function are unknown. Neurological and cognitive effects associated with 
influenza infection have been reported throughout history (following the 1918 “Spanish” flu), as 
well as during the recent novel influenza A HIN1 pandemic, but the mechanisms underlying 
these symptoms remain unclear (Ravenholt and Foege, 1982; Studahl, 2003; CDC, 2009; 
Gonzalez-Duarte et al., 2010). Most influenza strains, including those responsible for 
pandemics, are considered non-neurotropic (Schlesinger et al., 1998; Kobasa et al., 2007; 
Wang et al., 2010), suggesting that neurological symptoms associated with influenza infection 
are not a result of direct viral invasion into CNS regions relevant to cognitive behavior, but 
instead may be due to neuroinflammation induced by peripheral viral infection. 
Previous work from our lab and others has shown that activation of the peripheral innate 
immune system induces production of cytokines including interleukin-1β (IL-1β), IL-6 and tumor 
necrosis-α (TNF-α) within the brain that can have deleterious effects on cognitive and emotional 
behavior (Sparkman et al., 2006; Chen et al., 2008; Dantzer et al., 2008; Yirmiya and Goshen, 
2011). Inflammatory cytokines can negatively affect hippocampal function by directly impairing 
long-term potentiation (LTP) (Lynch, 2002; Pickering and O'Connor, 2007), as well as via the 
inhibition of neurotrophins (Tong et al., 2008) which are important for neuron survival and 
function, as well as synaptic plasticity and memory formation (Poo, 2001; Tyler et al., 2002; 
Minichiello, 2009). In addition, architectural changes to hippocampal neuron morphology have 
been reported following both peripheral and central administration of lipopolysaccharide (LPS), 
a component of Gram-negative bacteria that induces an innate immune response (Milatovic et 
al., 2003; Richwine et al., 2008).  As alterations in dendritic branching and spine density can 
affect synaptic plasticity (Neves et al., 2008; Spruston, 2008; Kasai et al., 2010), inflammation-
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induced changes in neuronal complexity may underlie functional deficits in hippocampal-
dependent learning and memory. 
Given that viral pathogens such as influenza are common and highly contagious, it is 
important to assess the effects of peripheral viral infection on CNS structure and function. It is 
currently unknown if infection with influenza virus can result in a central inflammatory response, 
neuronal damage and long-term neurobehavioral effects. Therefore the goal of this study was to 
use a mouse model of influenza to determine the impact of peripheral viral infection on 
hippocampal structure and function. We found that mice infected with live influenza A/PR8/34 
(H1N1) exhibited increased hippocampal neuroinflammation and cognitive deficits that were 
paralleled by the loss of neurotrophic factors and significant alterations in CA1 and dentate 
gyrus neuron morphology. These findings are the first to suggest that altered hippocampal 
structural plasticity may underlie cognitive impairment during influenza infection.  
 
3.3 Materials and Methods 
Animals 
For all studies, adult (4-6 months old) male Balb/c mice from our in-house colony were 
used. Mice were individually housed in polypropylene cages under a reverse 12:12 hour 
light:dark cycle at 24°C and given ad libitum access to food and water. All animal care and 
experimental procedures are in accordance with the National Institute of Health Guidelines for 
the Care and Use of Laboratory Animals and approved by the University of Illinois Institutional 
Animal Care and Use Committee. 
 
Mouse viral infection     
Mouse-adapted human influenza A/Puerto Rico/8/34 (H1N1) virus was a generous gift 
from Dr. John Sheridan and Dr. David Padgett (The Ohio State University). Mice were lightly 
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anesthetized with isoflurane and intranasally (i.n.) inoculated with 1 hemagglutinating unit (HAU) 
of influenza A/PR/8/34 virus in 50 µl sterile PBS. Control animals were inoculated (i.n.) with 50 
µl of sterile PBS. Use of isoflurane anesthesia allowed for quick recovery (<2min) and accurate 
delivery of viral dose. Following viral infection, mice were monitored daily for signs of morbidity 
including response to handling, food intake, and physical appearance (ruffled fur, huddled or 
hunched behavior).  In addition, changes in body weight and locomotor activity were used as 
more objective measures of disease progression. In mouse models of influenza, weight loss is 
considered a reliable way to track disease progress (Matsuoka et al., 2009). Body weight was 
measured at the same time daily (between 09:00-10:00) and percent change from initial body 
weight (day 0) was calculated. Previous studies (Lowder et al., 2005) have shown that during 
influenza infection, mice can lose a substantial amount of body weight (30-35%) and still 
recover, however as an established humane endpoint, mice that reached a 30% loss of their 
initial body weight were euthanized (day 7 post-inoculation). 
 
Influenza virus M1 expression 
To determine viral infection over the timecourse of influenza disease progression, a 
group of mice (n = 4-5 per group; control vs. influenza) were inoculated and lung and brain 
tissue was collected at 1, 4 and 7 days post-inoculation for measurement of mRNA expression 
of influenza matrix (M1) protein.  Since M1 is conserved among mouse-adapted influenza 
viruses and is an internal protein within the viral envelope, M1 mRNA correlates with virus levels 
in infected tissues (Fouchier et al., 2000; Nogusa et al., 2008). In addition, the sensitivity of RT-
PCR allows for detection of very low levels of the virus (Ward et al., 2004).  
 
Locomotor behavior 
In a cohort of mice (n = 5-6 per group; control vs. influenza) spontaneous locomotor 
activity was measured prior to intranasal inoculation (day 0), and for 7 days following inoculation 
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in order to investigate influenza-induced sickness behavior. Behavioral testing was conducted 
during the dark phase (between 09:00-11:00) of the photoperiod under infrared lighting to aid 
video recording. Mice were maintained in their home cage and locomotor activity was video 
recorded during 5 minute tests. A computerized animal tracking system (Ethovision; Noldus 
Information Technologies) was used to measure total distance moved during the testing period. 
At 7 days post-inoculation mice were euthanized and brains collected for immunohistochemistry 
(detailed methods for immunohistochemistry below). 
 
Morris water maze 
In a separate study, mice (n = 10-12 per group; control vs. influenza) were inoculated 
and the effects of influenza on spatial learning and memory were assessed in a reversal 
learning version of the Morris water maze. In this hippocampal-dependent task, the animal must 
learn to use distinctive distal visuo-spatial cues surrounding the pool to navigate a direct path to 
the hidden platform (Morris, 1984; D'Hooge and De Deyn, 2001).  The Morris water maze 
(MWM) consisted of a circular pool (100 cm diameter, 23–25 °C) with a transparent round 
platform (10 cm diameter) hidden 0.5 cm below the surface of the water. Mice were inoculated 
(day 0) and 2 days later began a 5 day acquisition phase (day 2-6 post-inoculation). The 
platform remained in a constant location during the acquisition testing. Animals were placed on 
the platform for 30 seconds preceding the start of each testing session. The trials were 
conducted using a pseudorandom protocol in which mice were placed in the water in one of 
three preset entry locations. Mice were allowed to swim freely for 60 seconds or until the 
platform was reached. If the platform was not located during the 60 seconds, mice were guided 
to the platform and allowed to remain for 30 seconds. After completion of three consecutive 
trials, mice were placed in their home cage under a heat lamp to dry for 10 minutes. On day 7 
post-inoculation (24 hours after the last day of acquisition testing), the platform was removed 
and mice received a 30 second probe trial to assess spatial memory for the platform location. 
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Following the probe trial, mice were subjected to a reversal test in which the hidden platform 
was moved to the opposite quadrant of the pool but all distal visual cues remained constant. 
Animals were placed on the platform for 30 seconds preceding the start of the reversal test and 
given three trials to locate the platform in the new target quadrant. Reversal learning measures 
how quickly an animal is able to extinguish their initial learning of the platform’s position and 
acquire a direct path to the new location (Vorhees and Williams, 2006). A video camera in 
conjunction with a computerized animal tracking system (Ethovision; Noldus Information 
Technologies) was used to record swim speed, latency to the platform and distance swam 
(pathlength to the platform).  
 
Quantitative real-time PCR 
After completion of behavioral testing, mice were killed by CO2 asphyxiation and blood 
and tissue samples were quickly collected. Total RNA was isolated from homogenized tissue 
using the Tri Reagent protocol (Sigma, St. Louis, MO). A QuantiTect Reverse Transcription Kit 
(Qiagen, Valencia, CA) was used for cDNA synthesis with integrated removal of genomic DNA 
contamination according to the manufacturer protocol. Quantitative real-time PCR was 
performed using the Applied Biosystems (Foster, CA) Assay-on Demand Gene Expression 
protocol. In short, cDNA was amplified by PCR where a target cDNA (IL-1β, IL-6, TNF-α, 
interferon-α (IFN-α), IFN-β, IFN-γ, major histocompatibility complex (MHC class II), brain-
derived neurotrophic factor (BDNF), nerve-growth factor (NGF), CD200, CX3CL1 (fractalkine), 
and influenza matrix M1) and a reference cDNA (glucose-3 phosphate dehydrogenase) were 
amplified simultaneously using an oligonucleotide probe with a 5′ fluorescent reporter dye (6-
FAM) and a 3′ quencher dye (NFQ). PCR reactions were performed at the following conditions: 
50 °C for 2 min, 95 °C for 10 min, followed by 40 cycles of 95 °C for 15 s, and 60 °C for 1 min. 
Fluorescence was determined on an ABI PRISM 7900HT-sequence detection system (Perkin 
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Elmer, Forest City, CA). Data were analyzed using the comparative threshold cycle (Ct) method, 
and results are expressed as fold change (Schmittgen and Livak, 2008).  
 
Immunohistochemical staining and quantification 
For determination of change in microglial reactivity a group of mice (n=5-6 per treatment 
group; control vs. influenza) were infected and brains were collected 7 days post-inoculation for 
immunohistochemical staining of Iba-1 (ionized calcium binding adaptor molecule 1) expression. 
Mice were deeply anesthetized via CO2 inhalation and transcardially perfused with 2 mM EDTA 
saline followed by 4% paraformaldehyde and whole brains were quickly removed. Brains were 
blocked at the optic chiasm (anterior, posterior) and post-fixed over 2 days in 4% 
paraformaldehyde, and then paraffin embedded. Coronal sections (4 μm) were cut on a 
microtome and stained for Iba-1 at the level of the hippocampus. Sections were dewaxed and 
rehydrated through xylene and alcohols and were incubated in citrate buffer, pH 6, and 
microwaved for 10 minutes. Endogenous peroxidase was eliminated by incubating sections in 
3% H2O2/methanol for 15 minutes. Sections were washed in PBS and blocked with 5% normal 
goat serum in PBS before overnight incubation at 4 °C with the primary antibody at 1:1600 
dilution in 5% blocking serum. The sections were washed, and then incubated with biotinylated 
goat anti-rabbit antibody (1:500 in 5% blocking serum) for 1 hour. Staining was visualized using 
the ABC method with 3,3′-diaminobenzidine (DAB) as the chromagen. Sections were 
counterstained with hemotoxylin. Isotype-matched IgG was used as negative control. Brains 
were coded prior to sectioning to ensure that experimenters were blind to treatments.  
Alterations in microglia reactivity were quantified using both digital image analysis (DIA) 
(Donnelly et al., 2009) to determine the area of Iba-1 immunostaining, and manual cell counts to 
quantify the number of Iba-1 positive cells. Iba-1 expression was quantified in the CA1, CA3 and 
dentate gyrus (DG) regions of the dorsal hippocampus (Bregma -1.46 to -2.46). For each 
animal, 8 images were taken from each hippocampal region (CA1, CA3 and DG) at 40X 
49 
 
magnification. For DIA, a threshold for Iba-1 positive staining was determined and Image J 
software (http://rsbweb.nih.gov/ij/) was used to quantify the area of thresholded material within a 
given region. Proportional area was calculated as the percentage area in the positive threshold 
relative to total area for each image. For cell counts, the number of Iba-1 positive cells was 
determined for each section and expressed as mean number of cells/mm2 . To obtain an 
estimate of the average size of the Iba-1 positive cells, the average area of Iba-1 positive 
thresholded material was divided by the number of Iba-1 positive cells for each image (Tynan et 
al., 2010).  
 
Hippocampal Neuronal Architecture 
For determination of the effect of influenza on hippocampal neuronal architecture, a 
group of mice (n = 5-6 per treatment group; control vs. influenza) were inoculated and at 7 days 
post-inoculation, were killed by CO2 asphyxiation and whole brain was quickly removed and 
processed for Golgi-Cox staining as described (Markham et al., 2005; Richwine et al., 2008). 
Briefly, whole brain was submerged in Golgi–Cox solution for 11 days, at which time test slices 
were taken to determine if neurons were well-filled. The brain was then coronally blocked at the 
optic chiasm and dehydrated. Brains were embedded in 12% celloiden and 150 μm thick 
coronal sections were cut on a microtome. Slices were developed according to (Glaser and Van 
der Loos, 1981) and mounted on glass slides. Brains were coded prior to sectioning to ensure 
that experimenters were blind to treatments.  
To evaluate hippocampal neuron morphology, a Zeiss Axio Imager A.1 microscope 
(Gottingen, Germany) and a computer-based system (Neurolucida; MicroBrightField, Williston, 
VT) was used to generate three-dimensional neuron tracings that were subsequently visualized 
and analyzed using NeuroExplorer (MicroBrightField, Williston, VT). In order for a neuron to be 
selected the following four criteria were met: (1) neuron was in the area of interest, (2) neuron 
was distinct from other neurons to allow for identification of dendrites, (3) neuron was not 
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truncated, and (4) neuron exhibited dark, well-filled staining throughout (Gould et al., 1990). For 
each animal, pyramidal cells in the CA1 region (Figure 3.1A) and granule cells in the 
suprapyramidal blade of the dentate gyrus (Figure 3.1D) were traced in the dorsal hippocampus 
(Bregma -1.46 to -2.70) at 100X magnification. For each reconstructed neuron, an estimate of 
dendritic complexity was obtained using the Sholl ring method. A 3-D Sholl analysis was 
performed in which concentric spheres of increasing radius (in 20 µm increments) were layered 
around the cell body until dendrites were completely encompassed (Figure 3.1B and D). The 
number of dendritic intersections at each increment was counted, and results were expressed 
as total intersections and the number of intersections per radial distance from the soma. For 
CA1 pyramidal neurons (n=4-5 cells per animal), both the apical and basal trees were traced, 
and morphological measurements were analyzed separately. As previous work has shown that 
the morphology of dentate gyrus granule neurons varies by soma location within the granule cell 
layer (GCL) (Green and Juraska, 1985; Wang et al., 2000), for each animal, 5-6 cells located in 
the inner one-third of the GCL (near the hilus), and 5-6 neurons located in the remaining two-
thirds of the granule cell layer (near the molecular layer) were traced for a total of 10-12 dentate 
granule cells per animal. 
For all neurons, spine density was measured on the same dendritic branches used for 
Sholl analysis. For CA1 pyramidal neurons, dendritic spine density was measured on 3 dendritic 
segments from both the basal and apical tree. For the basal tree, spines were counted along 
10-20 µm segments of 2-5° order branches located at least 50 µm away from the cell body. For 
the apical tree, spines were counted along 10-20 µm segments of tertiary oblique apical 
branches. For dentate gyrus granule cells, dendritic spine density was measured on 3 dendritic 
segments of 2-5° order branches located at least 50 µm away from the cell body. All 
measurements of spine density were taken from 1-2 µm thick dendritic segments in order to 
minimize the number of spines hidden by the dendritic shaft and ensure that the number of 
hidden spines was proportional across all segments counted and among treatment groups. The 
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total number of dendritic spines visible along both sides of the segment was counted and 
expressed as number of spines per micron of dendrite. 
 
Statistical analysis 
Differences in body weight, locomotor behavior, acquisition in the water maze and Sholl 
plots were tested with a repeated measures ANOVA using treatment (control vs. influenza 
infection) as the between-subjects factor. The within-subjects factors used were as follows: day 
post-inoculation (body weight and locomotor activity), testing day (water maze acquisition) and 
radial distance from the soma (Sholl plots). Iba-1 immunohistochemistry data were subjected to 
a 2-way ANOVA in which treatment (control vs. influenza) and hippocampal region (CA1, CA3, 
and DG) were independent variables. Morphological data (Sholl analysis and spine density) for 
dentate gyrus granule cells were subjected to a 2-way ANOVA in which treatment (control vs. 
influenza) and soma location in the granule cell layer (inner vs. outer) were independent 
variables. Since influenza M1 expression was non-detectable in control samples, Student’s t-
test using Fisher’s least significant differences was employed to determine if means for days 
post-inoculation were significantly different from each other. All other data (hippocampal gene 
expression, water maze reversal test and probe trial, and CA1 apical and basal tree morphology 
(Sholl analysis and spine density) were subjected to a one-way ANOVA in which treatment 
(control vs. influenza) was the independent variable. When the ANOVAs revealed a significant 
main effect or interaction between main factors, post hoc Student’s t-test using Fisher’s least 
significant differences was employed to determine if treatment means were significantly different 
from one another (p < 0.05). All data are presented as means ± SEM. 
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3.4 Results 
Influenza-induced sickness behavior and viral expression 
Changes in body weight and locomotor behavior were used to measure the sickness 
response to influenza infection. For the body weight data, repeated measures ANOVA revealed 
an effect of treatment (p<.0001), day (p<.0001) and treatment x day interaction (p<.0001) 
indicating that mice infected with influenza lost more body weight than controls over the 7-day 
post-inoculation timecourse (Figure 3.2A). The data for locomotor activity followed the same 
pattern, with an effect of treatment (p=0.0007), day (p<.0001) and treatment x day interaction 
(p<.0001) indicating that following influenza infection, locomotor activity became increasingly 
depressed (Figure 3.2B). Overall these data show that sickness behavior was first evident on 
day 3 post-inoculation and as the disease progressed, both weight and locomotor activity 
declined until day 7 post-inoculation when mice were euthanized. Real-time PCR was used to 
measure mRNA expression of influenza matrix (M1) protein in lung and brain tissue. Using the 
expression of this late viral gene product as a surrogate marker for virus replication (Fouchier et 
al., 2000), these data demonstrated that influenza M1 expression was detectable in the lungs by 
day 1 post-inoculation and remained elevated at both day 4 (p<.001) and day 7 (p=0.0034) 
post-inoculation (Table 3.1). Influenza M1 was non-detectable (ND) in control lung tissue or in 
hippocampal tissue from control or infected animals at any timepoint. 
 
Influenza infection impairs reversal learning in the Morris water maze 
In the Morris water maze (MWM), a decrease in time (latency) to find the hidden platform or a 
decrease in pathlength (distance) to the platform, indicate an improvement in spatial learning 
and memory. Since latency to reach the platform can be affected by motor function (swim 
speed) and motivation, distance swam is considered a more reliable measure of learning and 
memory performance (Contet et al., 2001; Cunningham and Sanderson, 2008). As expected, 
mice infected with influenza showed reduced swim speeds over the course of MWM testing 
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(data not shown); therefore distance to the platform was used to determine the performance of 
mice during both acquisition and reversal testing. For the acquisition data, repeated measures 
ANOVA revealed an effect of day (p<.0001), but no effect of treatment (p=0.406) or treatment x 
day interaction (p=0.987), indicating that during acquisition, both control and infected mice 
demonstrated improved performance (shorter pathlength) over testing days and appear to 
acquire the task at the same rate (Figure 3.3A). The results suggest that even though mice 
infected with influenza move slower, they are as “accurate” as control mice in locating the 
hidden platform. The results of the probe trial showed no difference (p=0.916) in the amount of 
time influenza-infected mice spent in the target quadrant compared to controls (Figure 3.3B). As 
both control and infected mice spent nearly 70% (25% is chance) of their time in the correct 
quadrant, it is apparent that both groups learned and remembered the location of the hidden 
platform to a high degree. While influenza-infected mice were able to both acquire the task and 
remember the location of the hidden platform as well as controls, cognitive deficits were 
revealed during reversal testing. When the hidden platform was moved to the opposite 
quadrant, infected mice showed impaired ability to efficiently navigate to the new location as 
shown in by an increase in pathlength to the new platform location compared to controls 
(p=0.037) (Figure 3.4A). While all mice initially continued to search the quadrant in which the 
platform was located during acquisition training, infected mice spent significantly more time 
(51%) returning to the incorrect quadrant compared to controls (38%) (p=0.048) (data not 
shown), indicating increased perseverative behavior. Additional analysis employed a 2-way 
ANOVA to examine the effects of treatment (control vs. flu) across trials for the time mice spent 
searching the correct quadrant location during reversal testing. There was a main effect of 
treatment (p=.0005), indicating that control animals spent more time searching the correct 
quadrant during reversal testing, and a main effect of trial (p=0.021), with both control and 
influenza-infected mice increasing the time spent in the correct quadrant as trials progressed. 
Post-hoc analysis showed that influenza-infected mice spent significantly less time searching 
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the correct quadrant during both Trial 1 (p=0.008) and Trial 3 (p= 0.034), suggesting a failure to 
update their search strategy when compared to control mice (Figure 3.4B). 
 
Influenza infection increases inflammatory cytokines and decreases neurotrophic and 
immunomodulatory factors 
Data in Figure 3.5A show that expression levels of inflammatory cytokines IL-1β 
(p=0.008), IL-6 (p=0.002) and TNF-α (p=0.001) were elevated in the hippocampus of influenza-
infected mice at day 7 post-inoculation, the same timepoint in which cognitive impairment was 
evident. In addition, MHC-II, a marker of microglia activation (Kreutzberg, 1996; Lynch, 2009) 
was also upregulated (p=0.0002), suggesting that increased microglial activation may underlie 
this neuroinflammatory response.  IFN-α was also increased in the hippocampus (p=0.004), but 
there was no effect of influenza infection on IFN-β (p=0.331) or IFN-γ levels (p=0.987) (Figure 
3.5B). Influenza infection decreased hippocampal expression of neurotrophins BDNF (p= 0.003) 
and NGF (p=0.0001), as well as immunomodulatory factors CD200 (p=0.031) and CX3CL1 
(fractalkine) (p=0.0004) (Figure 3.5C). 
 
Influenza infection increases microglia reactivity in the hippocampus 
To determine if influenza infection altered microglial reactivity, the proportional area of 
Iba-1 immunostaining (area of positive thresholded material relative to the total area) was 
determined using digital image analysis. Data were subjected to a 2-way ANOVA to examine 
the effects of treatment (control vs. flu) across hippocampal region (DG, CA1, CA3). There was 
a main effect of influenza infection (p=0.0003), but no effect of region (p=0.544) or interaction 
(p=0.992), indicating influenza increased Iba-1 expression throughout the hippocampus (Figure 
3.6A). As a difference in the area occupied by Iba-1 immunostaining could reflect a change in 
cell number, a change in cell size (morphology) or both, the number of Iba-1 positive cells and 
an estimate of their average size were also determined. For Iba-1 positive cell counts, there was 
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a main effect of influenza infection (p<.0001), but no effect of region (p=0.186) or interaction 
(p=0.821), indicating influenza increased the number if Iba-1 positive cells throughout the 
hippocampus (Figure 3.6B). There was no effect of influenza infection (p=0.107) or region 
(p=0.378) on the average size of Iba-1 positive cells (data not shown).  
 
Influenza infection alters hippocampal neuron morphology 
Dendritic arborization 
For CA1 pyramidal neurons, both the apical and basal trees were traced, and 
morphological measurements were analyzed separately. There was no effect of influenza 
infection on the total number of dendritic intersections in the apical (p=0.434) or basal (p=0.699) 
trees of CA1 pyramidal neurons (Figure 3.7A). Further analysis of apical dendritic branching 
revealed an effect of influenza (p<.05) on the number of intersections at distances of 200-240 
µm from the soma (Figure 3.7B), suggesting influenza-induced alterations in the distal portion of 
the apical tree. Morphological analyses of the CA1 basal tree found that influenza infection did 
not alter dendritic branching patterns as determined by Sholl analysis (data not shown).  
For dentate gyrus granule cells, a 2-way ANOVA revealed a main effect of soma location 
in the granule cell layer (GCL) (inner vs. outer GCL) (p=0.0023) and treatment (control vs. flu) 
(p=0.049), indicating less arborization of dentate granule cells (DGCs) in the innermost portion 
of GCL, and an influenza-induced decrease in dendritic extent to some degree in both 
populations. Post-hoc analysis showed that when separated out by soma location, only cells 
located in the outer portion of the GCL demonstrated a reduction in total intersections (p=0.028) 
following influenza infection when compared to controls (Figure 3.8A). Because we found a 
main effect of soma location (inner vs. outer GCL) on total dendritic intersections, and previous 
work has shown that the morphology of dentate gyrus granule neurons varies by soma location 
within the granule cell layer (Green and Juraska, 1985; Wang et al., 2000), dentate granule cells 
were separated based on soma location (inner vs. outer GCL) for further morphological analysis 
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of dendritic arbors.  For dentate granule neurons in both the inner and outer portion of the 
granule cell layer, repeated measures ANOVA revealed an interaction (p<.0001) between 
treatment (control vs. influenza) and interval distance from the soma (µm), indicating that 
influenza infection altered the shape of the dendritic tree in both of these subpopulations (Figure 
3.8B and C). The altered dendritic arborization of inner DGCs was due to a retraction in the 
distal dendrites (160-220 µm from the soma) (p<.05), and an increase in dendritic extent near 
the soma (40-80 µm from the soma) (p< .05) in influenza mice when compared to controls 
(Figure 3.8B). For dentate granule neurons located in the outer portion of the GCL, influenza 
infection induced a retraction of dendrites in both the middle and distal (140-200 µm from the 
soma) (p<.05) regions of the dendritic tree (Figure 3.8C). 
 
Dendritic spine density 
For CA1 pyramidal neurons, spine density was calculated and analyzed separately for 
apical and basal dendritic trees. Influenza infection did not alter the spine density of CA1 apical 
or basal dendrites (Figure 3.9B). For dentate granule neurons, a 2-way ANOVA determined the 
effect of location in the GCL (inner vs. outer) and treatment (control vs. influenza) on dendritic 
spine density. There was a main effect of location (p=0.0013) with overall increased dendritic 
spine density on cells in the outer dentate gyrus. In addition a treatment by location interaction 
(p=0.0274) suggested that the effects of influenza on spine density differed by soma location. 
Post-hoc analysis revealed that dentate granule cells residing in the inner portion of the GCL 
had reduced spine density (p=0.0138) following influenza infection, while cells in the outer 
portion of the GCL were not affected (p=0.5563) (Figure 3.9C). 
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3.5 Discussion 
The current study determined the impact of peripheral influenza infection on the 
neuroimmune response, hippocampal neuron morphology and cognitive function in adult mice. 
Infected mice exhibited cognitive impairment during reversal learning that was paralleled by 
increased hippocampal expression of proinflammatory cytokines and the loss of neurotrophic 
and immunomodulatory factors. Increased microglia reactivity and alterations in neuronal 
architecture were evident in the hippocampus at the same timepoint in which cognitive deficits 
were apparent. These data are the first to show that influenza infection affects hippocampal 
structural plasticity in both the CA1 and dentate gyrus. These structural changes may contribute 
to the long-lasting deleterious effects of influenza on cognitive function.  
 
Effects of influenza infection on cognitive function  
Influenza-induced cognitive deficits were revealed during reversal testing when infected 
mice showed impaired ability to efficiently navigate to the new platform location.  Overall, the 
infected mice demonstrated a failure to update their search strategy and increased 
perseverative behavior when compared to control mice.  This pattern of behavior is similar to 
previous work showing that hippocampal-lesioned animals can acquire a place response in the 
water maze, but are impaired during reversal learning due to perseverative returns to the 
previous correct location (Whishaw and Tomie, 1997; Whishaw, 1998). Thus, the present 
results indicate that influenza infection inhibited normal hippocampal function. While 
hippocampal damage can disrupt spatial reversal learning, regions including the frontal cortex 
(Kesner and Churchwell, 2011) and striatum (Wei et al., 2011) are also involved, and could be 
additional targets of influenza infection.                       
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Effects of influenza infection on hippocampal gene expression  
At the same timepoint in which cognitive deficits were evident, proinflammatory and anti-
viral mediators (IL-1β, IL-6,TNF-α, MHC-II and IFN-α), were elevated in the hippocampus of 
influenza-infected mice, indicating neuroinflammation and microglial activation in a region 
relevant to spatial learning and memory. Although cytokines induced by LPS, and in particular 
IL-1β, are known to alter learning and memory (McAfoose and Baune, 2009; Yirmiya and 
Goshen, 2011), less is known regarding the cognitive effects of virally-induced interferons. 
Interferon therapy in humans produces flu-like symptoms and adverse neuropsychological 
effects including memory alterations and depression (Valentine et al., 1998; Capuron and Miller, 
2004). In rodents IFN-α can alter cognitive function, with overexpression resulting in 
neuroinflammation and neurodegeneration (Campbell et al., 1999; Sas et al., 2007; Sas et al., 
2009). While the type-I interferon response is crucial to control viral infection in the periphery 
(Wolff and Ludwig, 2009), increased expression of IFN-α in the hippocampus during influenza 
infection could contribute to cognitive dysfunction and neuronal damage.  
While infection increased inflammatory mediators, neurotrophic factors (BDNF, NGF) 
were decreased in the hippocampus of infected mice. These findings are similar to previous 
work demonstrating reduced neurotrophins in the hippocampus of both adult and aged rodents 
following peripheral administration of LPS or E. coli infection (Guan and Fang, 2006; Richwine 
et al., 2008; Chapman et al., 2011). The loss of neurotrophic factors essential to neuron survival 
and function (Poo, 2001; Chao, 2003; Minichiello, 2009), could contribute to cognitive 
impairment and leave the brain vulnerable during influenza infection.  
Although neurotrophic factors are well-known for their role in neuron support and 
survival, they also help maintain microglia in a resting state (Neumann et al., 1998). Healthy 
neurons maintain microglia in a quiescent state via signals including CD200, CX3CL1 
(fractalkine), neurotransmitters and neurotrophins (Biber et al., 2008; Tian et al., 2009). 
Immunomodulatory factors CD200 and CX3CL1 are constitutively expressed in the brain and 
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play an important role in down-regulating inflammation and microglial activation during aging, 
stress and disease (Hoek et al., 2000; Cardona et al., 2006; Frank et al., 2007; Jurgens and 
Johnson, 2010; Wynne et al., 2010). The loss of neurotrophins, along with reduced expression 
of CD200 and CX3CL1, could impede neuron-microglia interactions and shift microglia from a 
resting to a reactive state during influenza infection. Influenza-induced loss of this cross-talk 
could have detrimental effects on neuronal function as it has been shown that CD200-deficiency 
impairs hippocampal synaptic plasticity (Costello et al., 2011). 
 
Effects of influenza infection on microglial reactivity 
While termed “resting”, microglia in the healthy adult brain play an active role in 
maintaining the integrity of the CNS by continuously scanning the brain parenchyma for 
alterations in homeostasis and monitoring the functional state of synapses (Nimmerjahn et al., 
2005; Wake et al., 2009). Sensitive to changes in their microenvironment, microglia respond to 
insult by entering different states of activation that are dependent on the nature and duration of 
the stimulus (Hanisch and Kettenmann, 2007; Ransohoff and Perry, 2009). Although microglia 
activation is necessary for host defense, prolonged or aberrant activation can have damaging 
effects (Block et al., 2007). 
The loss of neuroimmune factors that keep microglia quiescent along with increased 
expression of MHC-II in the hippocampus suggests that influenza may alter the reactive state of 
microglia. To investigate this further, we used immunohistochemistry to measure Iba-1 
expression in the hippocampus. Iba-1 is expressed by microglia and is upregulated in response 
to immune-activating stimuli including stress, aging, and inflammation (Ito et al., 1998; Choi et 
al., 2007; Chung et al., 2010; Tynan et al., 2010). Our results show that Iba-1 expression was 
increased throughout the hippocampus of influenza-infected mice. The increase in proportional 
area of Iba-1 expression was driven by a significant increase in the number of Iba-1 positive 
cells, as the average cell size was not altered by influenza infection. 
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An increase in the number of Iba-1 positive cells could be due to proliferation of 
microglia as shown during stress or injury (Dihne et al., 2001; Nair and Bonneau, 2006; Ajami et 
al., 2007), or due to an increase in Iba-1 expression that allowed cells previously below the level 
of detection to become detectable (Tynan et al., 2010). Although, specific analyses of cell 
surface markers would be needed to determine if Iba-1 positive cells were resident microglia 
versus trafficking CNS macrophages (Mildner et al., 2007; Ransohoff and Perry, 2009), the 
overall increase in Iba-1 expression indicates an altered neuroimmune response in the brain 
during peripheral viral infection. 
 
Effects of Influenza infection on hippocampal neuron morphology  
As neuroinflammation can contribute to hippocampal dendritic atrophy (Milatovic et al., 
2003; Richwine et al., 2008), we next determined if influenza infection altered dendritic 
branching and spine density of hippocampal neurons in the CA1 region and dentate gyrus. Our 
results showed that while both CA1 pyramidal neurons and dentate granule neurons 
demonstrated retraction of distal dendrites following infection, the architecture of granule cells 
was more profoundly affected.  
Since the morphology of granule neurons varies by soma location within the granule cell 
layer (GCL) (Green and Juraska, 1985; Wang et al., 2000), we also determined if influenza 
differentially affected dentate granule cells (DGCs) residing in the inner versus the outer 
portions of the GCL. The results showed that influenza infection induced a significant loss of 
distal dendrites in both subpopulations, but only neurons located in the inner portion of the GCL 
demonstrated increased proximal branching. These data indicated that outer DGCs 
demonstrated overall dendritic atrophy, while inner DGCs showed evidence of dendritic 
reorganization.  
Along with different structural features, placement within the granular cell layer is also 
associated with the “age” of the neuron, with the inner third of the GCL containing a high 
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proportion of neurons generated during adult neurogenesis, while the outer layers contain 
mostly mature neurons generated during development (Altman and Bayer, 1990; Esposito et al., 
2005; Mathews et al., 2010; Mongiat and Schinder, 2011). While the methods employed here do 
not allow for determination of neuron maturity, it is possible the microenvironment of the 
innermost GCL, with continuous network remodeling due to the addition of adult-born neurons 
(Mongiat and Schinder, 2011), could influence the structural plasticity of existing neurons (both 
immature and mature) within this region. Increased dendritic branching near the soma of inner 
DGCs could be a compensatory mechanism aimed at maintaining overall synaptic contact 
following the loss of distal dendrites and reduction in spine density induced by influenza 
infection.  
Since the dentate gyrus as a whole plays an important role in spatial learning and 
memory (Kesner, 2007; Xavier and Costa, 2009), structural alterations, whether aberrant 
dendritic reorganization (inner DGCs), or overall atrophy (outer DGCs) could contribute to 
impaired performance in the water maze. While it is unknown if alterations in dendritic branching 
are indicative of protective or pathological remodeling (McEwen, 2010), changes in neuronal 
architecture in both the CA1 and dentate gyrus could impact hippocampal function and cognitive 
behavior during influenza infection.  
It is hypothesized that (over a lifetime), common respiratory viruses, such as influenza, 
can induce cumulative neuroinflammatory damage leaving the brain less resilient to future insult 
and contributing to neurodegeneration (Majde, 2010).  The results of this study are the first 
direct evidence that peripheral infection with influenza can induce neuroinflammation and 
alterations in the structural plasticity of the hippocampus, a brain region essential to cognition 
and vulnerable to degeneration. A better understanding of how peripheral viral infection alters 
the structure and function of the CNS will allow for the development of therapeutic strategies 
aimed at modulating the neuroimmune response and maintaining neuronal integrity. 
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3.6 Figures 
 
 
 
Figure 3.1. Representative examples of Golgi-stained neurons along with corresponding 3-D 
reconstruction and Sholl ring analysis in the CA1 (A and B) and dentate gyrus (C and D) 
subfields of the hippocampus. Arrows indicate neuron selected for tracing. Magnification = 20X, 
scale bar = 20 µm. 
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Figure 3.2. Sickness behavior following influenza infection.  Influenza infected mice lost a 
significant amount of body weight (A) and locomotor activity rapidly declined (B) over the course 
of influenza infection. Data are represented as means ± SEM.  (*p < 0.05 compared to controls). 
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Table 3.1. Influenza matrix (M1) protein mRNA expression in lung and brain tissue. Influenza 
M1 mRNA expression was measured in lung and hippocampal tissue at days 1, 4 and 7 
following inoculation with influenza virus. As viral M1 was non-detectable (ND) in control lung 
samples, data are expressed as fold change in mRNA expression from day 1 post-inoculation. 
Influenza M1 expression was elevated in the lungs of infected mice at day 4 and 7 post-
inoculation (* p< 0.05 compared to day 1 post-inoculation). Influenza M1 mRNA was non-
detectable (ND) in hippocampal tissue from control or influenza infected mice at any timepoint. 
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Figure 3.3. Morris water maze acquisition and probe trial. (A) Influenza infected and control 
animals demonstrated similar performance during acquisition of the task as measured by 
distance to reach the hidden platform over 5 days of testing. (B) A probe trial (24 hours following 
the last day of acquisition testing) indicated no significant difference in the amount of time 
influenza mice spend in the target quadrant compared to controls. 
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Figure 3.4. Morris water maze reversal testing. (A) Influenza infected mice demonstrated an 
increase in distance (pathlength) to reach the hidden platform when it was moved to the 
opposite quadrant during reversal testing. (B) Influenza infected mice spent less time searching 
the correct target quadrant across trials during reversal testing when compared to control mice. 
Data are represented as means ± SEM. (*p < 0.05, **p < 0.01 compared to controls). 
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Figure 3.5. Influenza infection altered hippocampal gene expression. (A) Inflammatory 
cytokines (IL-1β, IL-6, TNF-α) and MHCII (marker of microglial activation) were increased in the 
hippocampus of influenza-infected mice. (B) Influenza infection induced increased hippocampal 
expression of anti-viral cytokine IFN-α. (C) Neurotrophic (BDNF, NGF) and immunomodulatory 
factors (CD200, CX3CL1) were decreased in the hippocampus of influenza infected mice. All 
data are from day 7 post-inoculation. Data are represented as means ± SEM. (*p < 0.05, **p < 
0.01 compared to controls). 
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Figure 3.6. Influenza infection increased microglia reactivity. (A) Influenza infection increased 
the proportional area of Iba-1 staining in the hippocampus at day 7 post-infection (B)  Influenza 
infection increased the number of Iba-1 positive cells in the hippocampus at day 7 post-
inoculation. Representative examples of Iba-1 positive cells in the dentate gyrus of a control (C) 
and influenza-infected (D) animal. Inset includes enlarged image of Iba-1 positive cell indicated 
by arrow. Magnification = 40X, scale bar = 50 µm. Data are represented as means ± SEM. (*p < 
0.05, **p < 0.01, #p = .08 compared to controls). 
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Figure 3.7. Influenza infection altered CA1 pyramidal neuron morphology. (A) Influenza 
infection did not affect the total number of apical or basal tree dendritic intersections of CA1 
pyramidal neurons. (B) Influenza infection induced retraction of dendrites in the distal portion of 
the CA1 apical tree (reduced intersections 200-240 µm from the soma). Data are represented 
as means ± SEM. (*p < 0.05 compared to controls). 
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Figure 3.8. Influenza infection altered dentate granule neuron morphology. (A) Influenza 
infection reduced the total number of dendritic intersections of dentate granule neurons in the 
outer portion of the granule cell layer (GCL).  (B) Influenza infection induced retraction of distal 
dendrites (160-220 um from the soma) while increasing dendritic extent proximal to the cell 
body (40-80 µm from the soma) of dentate granule neurons residing in the inner portion of the 
GCL. (C) Influenza infection induced retraction of distal dendrites (140-200 µm from the soma) 
of dentate granule cells located in the outer portion of the GCL. Data are represented as means 
± SEM. (*p < 0.05 compared to controls). 
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Figure 3.9. Effects of influenza infection on spine density of hippocampal dendrites. (A) 
Representative image of Golgi-stained dendritic spines in the dentate gyrus. Magnification = 
100X, scale bar = 10 µm. (B) Influenza infection did not alter spine density of apical or basal 
dendrites in the CA1 region. (C) Influenza infection decreased dendritic spine density of dentate 
granule cells located in the inner portion of the granule cell layer (GCL). Data are represented 
as means ± SEM. (*p < 0.05 compared to controls). 
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CHAPTER 4 
ENVIRONMENTAL ENRICHMENT ATTENUATES HIPPOCAMPAL 
NEUROINFLAMMATION AND IMPROVES COGNITIVE FUNCTION DURING 
INFLUENZA INFECTION  
 
4.1 Abstract 
Recent findings from our lab have shown that peripheral infection of adult mice with 
influenza A/PR/8/34 (H1N1) virus induces a neuroinflammatory response that is paralleled by 
loss of neurotrophic and glial regulatory factors in the hippocampus, and deficits in cognitive 
function.  Environmental enrichment has been shown to exert beneficial effects on the brain and 
behavior in many central nervous system (CNS) disorders, but its therapeutic potential during 
peripheral viral infection remains unknown. Therefore, the objective of the present study was to 
determine if long-term continuous exposure to environmental enrichment could prevent and/or 
attenuate the negative effects of influenza infection on the hippocampus and spatial cognition. 
Mice were housed in enriched or standard conditions for 4 months, and continued to live in their 
respective environments throughout influenza infection. Cognitive function was assessed in a 
reversal learning version of the Morris water maze, and changes in hippocampal expression of 
proinflammatory cytokines (IL-1β, IL-6, TNF-α, IFN-α), neurotrophic (BDNF, NGF), and 
immunomodulatory (CD200, CX3CL1) factors were determined. We found that environmental 
enrichment reduced neuroinflammation and helped prevent the influenza-induced blunting of 
neurotrophic and immunomodulatory factors. These changes were paralleled by improved 
cognitive performance of enriched mice infected with influenza when compared to infected mice 
in standard housing conditions. Collectively, these data are the first to demonstrate the positive 
impact of environmental enrichment on the brain and cognition during peripheral viral infection, 
and suggest that enhanced modulation of the neuroimmune response may underlie these 
beneficial effects.  
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4.2 Introduction 
Influenza is a common and highly contagious viral pathogen that remains a significant 
health concern worldwide. Neurological symptoms have been reported following respiratory 
infection with pandemic strains of influenza A (Ravenholt and Foege, 1982; Studahl, 2003; 
CDC, 2009; Wang et al., 2010), suggesting that peripheral infection can impact central nervous 
system (CNS) function. While the mechanisms underlying the effects of non-neurotropic viral 
strains on the brain remain unclear (Schlesinger et al., 1998; Studahl, 2003), it has been 
hypothesized that glia-mediated neuroinflammation in association with common respiratory 
viruses may lead to cumulative neuronal damage across the lifespan (Majde, 2010).  
Using a mouse model of influenza, we have recently shown that peripheral infection with 
influenza A/PR8/34 (H1N1) induces a neuroimmune response, and impacts hippocampal 
structure and function (Jurgens et al., in submission). Infected mice demonstrated cognitive 
deficits in hippocampal-dependent tasks that were paralleled by significant alterations in 
hippocampal neuron morphology in the CA1 region and dentate gyrus. Concurrent with 
cognitive impairment, influenza-infected mice had increased hippocampal expression of 
inflammatory cytokines (interleukin (IL)-1β, IL-6, tumor necrosis factor (TNF)-α and interferon 
(IFN)-α), and decreased expression of brain derived neurotrophic factor (BDNF) and nerve 
growth factor (NGF).  Previous work has shown that elevated levels of proinflammatory 
cytokines in the hippocampus can inhibit neurotropic factors (Barrientos et al., 2004; Tong et al., 
2008) and impair hippocampal synaptic plasticity (Mendoza-Fernandez et al., 2000; Lynch, 
2002; Pickering and O'Connor, 2007), providing a potential mechanism by which hippocampal 
neuroinflammation can induce cognitive dysfunction. In addition, influenza significantly reduced 
the levels of immunomodulatory factors CD200 and CX3CL1 (fractalkine), which play an 
important role in the neuronal control of microglia activation (Hoek et al., 2000; Cardona et al., 
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2006), and have recently been found to impact synaptic development and integrity (Costello et 
al., 2011; Paolicelli et al., 2011; Ransohoff and Stevens, 2011). Overall, the loss of neurotrophic 
support along with dysregulated neuron-microglia crosstalk, could negatively impact cognitive 
function and leave the brain vulnerable to inflammatory damage during influenza infection.    
A potential strategy for increasing brain plasticity and resiliency is environmental 
enrichment. Environmental enrichment (EE) is classically defined as a “complex combination of 
social and inanimate stimulation” (Rosenzweig and Bennett, 1996), in comparison to standard 
housing conditions. While there is variation in experimental protocols (Simpson and Kelly, 
2011), in general EE refers to conditions that provide increased social, cognitive, and physical 
stimulation. An enriched environment for rodents typically includes group housing in a large 
cage with nesting materials, various toys, tunnels and ladders for exploration, and running 
wheels for voluntary exercise (van Praag et al., 2000; Nithianantharajah and Hannan, 2006). 
Items of enrichment are routinely changed during the experimental period to maintain novelty 
and provide continuous opportunity for exploration and learning.  
Environmental enrichment has been shown to exert positive effects on cognitive and 
emotional behaviors including enhanced learning and memory (Nilsson et al., 1999; Bruel-
Jungerman et al., 2005; Leggio et al., 2005) and improved ability to cope with fear, anxiety and 
stress (Larsson et al., 2002; Fox et al., 2006; Schloesser et al., 2010). Early work demonstrated 
that exposure to a complex and stimulating environment could produce changes in neuron 
morphology, myelination and synaptogenesis during development, adulthood and aging 
(Bennett et al., 1969; Diamond et al., 1976; Green et al., 1983; Greenough et al., 1986; Juraska 
and Kopcik, 1988). This suggests that neural plasticity in response to environmental experience 
lasts throughout the lifespan. In addition to morphological changes, EE has also been shown to 
elevate levels of neurotrophic factors (Pham et al., 1999; Ickes et al., 2000) and synaptic 
proteins (Rampon et al., 2000; Nithianantharajah et al., 2004), as well as enhance hippocampal 
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synaptic plasticity (Green and Greenough, 1986; Artola et al., 2006) and increase neurogenesis 
(Kempermann et al., 1997; Rossi et al., 2006)  
While the beneficial effects of EE have been explored during aging, as well as in animal 
models of neurodegenerative disease, psychiatric disorders and brain injury (Will et al., 2004; 
Nithianantharajah and Hannan, 2006; Mora et al., 2007; Laviola et al., 2008), the impact of EE 
on the central immune response and cognitive behavior during peripheral viral infection remains 
unknown. Since influenza infection has been shown to negatively impact measures of 
hippocampal and cognitive function, which are influenced by EE, the present study sought to 
determine if the deleterious effects of influenza infection on the CNS could be prevented or 
attenuated by long-term continuous exposure to environmental enrichment.  We examined the 
impact of environmental enrichment on influenza-induced sickness response and cognitive 
behavior, and assessed changes in inflammatory, neurotrophic, and immunomodulatory factors 
in the hippocampus. We focused our study on the hippocampus, as this is a brain region that 
demonstrates a high degree of plasticity, is vulnerable to inflammation, and plays an important 
role in cognitive function.  We hypothesized that continuous exposure to an enriched 
environment during rearing and throughout influenza infection would help modulate 
inflammation, preserve levels of neurotrophic and glial regulatory factors, and prevent or reduce 
cognitive deficits induced by peripheral infection with live influenza virus. 
 
4.3 Materials and Methods 
Subjects 
Young (6 weeks old) male BALB/c mice were purchased from The Jackson Laboratory 
(Bar Harbor, ME). On arrival, mice were group housed and allowed at least 7 days to acclimate 
before experimental housing treatments were initiated. Following acclimation, animals were 
randomly assigned to the enriched environment (EE, n=5-8/cage) or standard environment (SE, 
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n=1/cage) conditions. Briefly, the enriched environment consisted of a large cage (100 x 51 x 37 
cm) equipped with toys, tunnels, ladders, housing chambers, nesting material and 2 running 
wheels (Figure 4.1). Mice were housed continuously in the enriched environment with 
rearrangement of toys, tunnels, and wheels 3-4 times per week to maintain novelty. The 
standard environment consisted of a laboratory polypropylene cage with bedding.  All mice were 
maintained under a reverse 12:12 h light:dark cycle at 24°C and given ad libitum access to food 
and water.  All animal care and experimental procedures are in accordance with the National 
Institute of Health Guidelines for the Care and Use of Laboratory Animals and approved by the 
University of Illinois Institutional Animal Care and Use Committee. 
 
Mouse viral infection 
Mouse-adapted human influenza A/Puerto Rico/8/34 (H1N1) virus was a generous gift 
from Dr. John Sheridan and Dr. David Padgett (The Ohio State University). Mice were lightly 
anesthetized with isoflurane and intranasally (i.n.) inoculated with 1 HAU (hemagglutinating unit) 
of influenza A/PR/8/34 virus in 50 µl sterile PBS. Control animals were inoculated (i.n.) with 50 
µl of sterile PBS. Use of isoflurane anesthesia allowed for quick recovery (<2min) and accurate 
delivery of viral dose. Following viral infection, mice were monitored daily for signs of morbidity, 
including response to handling, food intake, and physical appearance (i.e. ruffled fur, huddled or 
hunched behavior).  In mouse models of influenza, weight loss is considered a reliable indicator 
of disease progress (Matsuoka et al., 2009), thus body weight was measured at the same time 
daily (between 09:00-10:00) and percent change from initial body weight (day 0) was calculated. 
Previous studies (Lowder et al., 2005) have shown that during influenza infection, mice can lose 
a substantial amount of body weight (30-35%) and still recover, however as an established 
humane endpoint, mice that reached a 30% loss of their initial body weight were euthanized 
(day 7 post-inoculation). 
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Morris water maze 
The effects of environmental enrichment and influenza infection on spatial learning and 
memory were assessed in a reversal learning version of the Morris water maze. In this 
hippocampal-dependent task, the animal must learn to use distinctive distal visuo-spatial cues 
surrounding the pool to navigate a direct path to the hidden platform (Morris, 1984; D'Hooge 
and De Deyn, 2001).  The Morris water maze (MWM) consisted of a circular pool (130 cm 
diameter, 23–25 °C) with a transparent round platform (10 cm diameter) hidden 0.5 cm below 
the surface of the water. Mice were inoculated (day 0) and 2 days later began a 5-day 
acquisition phase (days 2-6 post-inoculation). The platform remained in the same location 
during the acquisition training. Animals were placed on the platform for 30 s preceding the start 
of each training session. The trials were conducted using a pseudorandom protocol in which 
mice were placed in the water in one of three preset entry locations. Mice were allowed to swim 
freely for 60 s or until the platform was reached. If the platform was not located during the 60 s, 
mice were guided to the platform and allowed to remain for 30 s. After completion of three 
consecutive trials, mice were placed in their home cage under a heat lamp to dry for 10 min. On 
day 7 post-inoculation (24 h after the last day of acquisition training), the platform was removed 
and mice received a 30 s probe trial to assess spatial memory for the platform location. 
Following the probe trial, mice were subjected to a reversal test in which the hidden platform 
was moved to the opposite quadrant of the pool, but all distal visual cues remained constant. 
Animals were placed on the platform for 30 s preceding the start of the reversal test, and given 
three trials to locate the platform in the new target quadrant. Reversal learning measures how 
quickly an animal is able to extinguish their initial learning of the platform’s position and acquire 
a direct path to the new location (Vorhees and Williams, 2006). A video camera in conjunction 
with a computerized animal tracking system (Ethovision; Noldus Information Technologies) was 
used to record swim speed, latency to the platform, and distance swam (pathlength to the 
platform).  
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Quantitative real-time PCR 
After completion of behavioral testing, mice were euthanized by CO2 asphyxiation and 
blood and tissue samples were quickly collected and stored in RNAlater at –80°C. Total RNA 
was isolated from homogenized tissue using the Tri Reagent protocol (Sigma, St. Louis, MO). A 
QuantiTect Reverse Transcription Kit (Qiagen, Valencia, CA) was used for cDNA synthesis with 
integrated removal of genomic DNA contamination according to the manufacturer protocol. 
Quantitative real-time PCR was performed using the Applied Biosystems (Foster, CA) Assay-on 
Demand Gene Expression protocol. In short, cDNA was amplified by PCR where a target cDNA 
(IL-1β, IL-6, TNF-α, IFN-α, BDNF, NGF, CD200, CX3CL1 and influenza matrix M1) and a 
reference cDNA (glucose-3 phosphate dehydrogenase) were amplified simultaneously using an 
oligonucleotide probe with a 5′ fluorescent reporter dye (6-FAM) and a 3′ quencher dye (NFQ). 
PCR reactions were performed at the following conditions: 50 °C for 2 min, 95 °C for 10 min, 
followed by 40 cycles of 95 °C for 15 s, and 60 °C for 1 min. Fluorescence was determined on 
an ABI PRISM 7900HT-sequence detection system (Perkin Elmer, Forest City, CA). Data were 
analyzed using the comparative threshold cycle (Ct) method, and results are expressed as fold 
change (Schmittgen and Livak, 2008). For cytokines, neurotrophic and immunomodulatory 
factors, results are expressed as fold change from standard-housed control mice. For M1 viral 
protein expression in the lung, results are expressed as fold change from lung tissue collected 
at day 1 post-inoculation as MI was non-detectable in control (non-infected) tissue.  
 
Experimental design 
Mice remained in their respective housing (SE or EE) continuously for 4 months (7-8 
weeks old to 6 months old).  At 6 months old, mice were inoculated with influenza A/PR8/34 
virus (1 HAU) or sterile PBS. Following inoculation, mice continued to live in their respective 
environments (SE or EE) throughout the entire post-inoculation period until they were 
euthanized for tissue collection at day 7 post-inoculation following behavioral testing.  For each 
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study, there were 2 enriched environment cages: one EE cage for control mice (n = 5-7/cage) 
and one EE cage for influenza-infected mice (n = 5-7/cage). For mice housed in the standard 
environment (SE), there were 6 cages of single-housed control mice, and 6 cages of single-
housed influenza-infected mice. Therefore, a 2x2 factorial design was employed in this study: 
SE, standard environment; EE, enriched environment; CON, control (PBS inoculation); FLU, 
influenza (1 HAU viral inoculation), thus creating four treatment groups: SE CON, SE FLU, EE 
CON, and EE FLU. Using identical experimental parameters, two replications were performed, 
resulting in a final treatment number of n = 10-12 for all treatment groups.  
 
Statistical Analysis 
Change in body weight and water maze acquisition data were subjected to a repeated 
measures ANOVA as a two-way design in which housing (standard vs. enriched) and treatment 
(control vs. influenza) were between-subjects factors.  The within-subjects factor for body weight 
was day post-inoculation, while the within-subjects factor for water maze data was day of 
acquisition training. All other data (gene expression, water maze reversal test and probe trial) 
were analyzed using a 2-way ANOVA in which housing (standard vs. enriched) and treatment 
(control vs. influenza) were independent variables. When the ANOVAs revealed a significant 
main effect or interaction between main factors, post hoc Student’s t-test using Fisher’s least 
significant differences was employed to determine if treatment means were significantly different 
from one another (p < 0.05). All data are presented as means ± SEM. 
 
4.4 Results 
Effects of environmental enrichment on influenza-induced sickness response 
For body weight data repeated measures ANOVA revealed an effect of treatment 
(p<.0001), day (p<.0001), and treatment x day interaction (p<.0001), indicating that mice 
infected with influenza lost more body weight than controls over the course of infection (Figure 
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4.2). While there was no main effect of housing (p=0.5139), there was an interaction of day x 
housing x treatment (p=0.0025), indicating that influenza differentially affected body weight in 
SE and EE mice across days post-infection. Post-hoc analysis revealed that SE FLU mice lost 
more weight than EE FLU mice on days 5 (p=0.028), day 6 (p=0.005) and day 7 (p=0.008) 
suggesting the environmental enrichment moderately attenuated the sickness response as the 
infection progressed. 
 
Effects of environmental enrichment on influenza-induced cognitive impairment 
In the Morris water maze (MWM), a decrease in time (latency) to find the hidden 
platform, or a decrease in pathlength (distance) to the platform, indicate an improvement in 
spatial learning. Since latency to reach the platform can be affected by motor function (swim 
speed) and motivation, distance swam is considered a more reliable measure of learning and 
memory performance (Contet et al., 2001; Cunningham and Sanderson, 2008), and therefore 
was used determine the performance of mice during both acquisition training and reversal 
testing. 
For the water maze acquisition data (Figure 4.3A), repeated measures ANOVA revealed 
a significant effect of day (p< .0001) indicating that mice in all treatment groups showed 
improved performance (shorter pathlength) over days of acquisition training.  The analysis also 
showed a main effect of housing (p=0.0006), indicating that mice in EE demonstrated superior 
performance to mice in SE and a main effect of treatment (p=0.0463), with influenza infection 
impairing water maze performance to some extent in both SE and EE mice.  The interaction of 
day x housing x treatment approached significance (p=0.0609), suggesting that influenza 
infection differentially altered the performance of SE versus EE mice over acquisition training.  
Post-hoc analysis of data from day 1 of acquisition training, showed that EE CON mice were 
initially better at locating the platform when compared to SE CON (p=0.0002) and SE FLU 
(p=0.0035) groups. Most importantly, the data analysis revealed that by the last day of 
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acquisition (day 5), SE FLU mice showed impaired performance compared to all other treatment 
groups (p<.01 for all comparisons), while EE FLU mice performed as well as both standard 
housed controls (p=0.931), and enriched controls (p=0.921). Overall the data suggested that 
enriched mice with influenza infection showed improved acquisition of the task when compared 
to influenza mice living in standard conditions.  
For the probe trial (Figure 4.3B), a 2-way ANOVA revealed an effect of housing 
(p=0.027), indicating that EE mice spent more time in the target quadrant than SE mice.  The 
analysis showed no effect of treatment (p=0.098), or housing x treatment interaction (p=0.291). 
However, post-hoc analysis revealed that SE FLU mice spent less time in the target quadrant 
than EE FLU mice (p=0.035), and EE CON mice (p=0.006), with near significance (p=0.056) 
toward less time than the SE CON group. Interestingly, there was no decrease in the amount of 
time EE FLU mice spent searching the target quadrant compared to EE CON mice (p=0.656) or 
SE CON mice (p=0.680), suggesting that environmental enrichment helped prevent the 
influenza-induced impairment in reference memory as assessed by probe trial performance. 
For reversal testing data (Figure 4.4), a 2-way ANOVA revealed an effect of treatment 
(p=0.021), but no effect of housing (p=0.129), or interaction (p=0.788), indicating that influenza 
infection impaired reversal learning (as indicated by increased pathlength to the new platform 
location) in mice from both standard and enriched environments. Post hoc analysis revealed 
that SE FLU mice performed worse than EE CON mice (p=0.006), with a trend towards impaired 
performance compared to the SE CON group (p=0.061), but were not impaired compared to the 
EE FLU mice (p=0.231).  
 
Effects of environmental enrichment and influenza on hippocampal cytokines 
Overall, the analysis showed that there was no main effect of housing (standard vs. 
enriched) on the expression of IL-1β (p=0.471), IL-6 (p=0.313), TNF-α (p=0.412), IFN-α 
(p=0.138) or IFN-β (p=0.056), indicating that basal levels of hippocampal cytokines were not 
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affected by living condition (Figures 4.5 and 4.6). For IL-1β expression, there was an effect of 
treatment (p=0.0005) and a housing x treatment interaction (p=0.0128) indicating influenza 
infection altered IL-1β expression differently in standard versus enriched mice (Figure 4.5A). SE 
FLU mice had increased IL-1β compared to both SE CON (p<.0001), as well as EE FLU 
(p=0.0285). Most interestingly, environmental enrichment attenuated the influenza-induced 
increase in IL-1β, as indicated by no difference in IL-1β levels in the EE CON versus EE FLU 
treatment groups (p=0.4139).  For TNF-α, there was an effect of treatment (p<.0001), and a 
housing x treatment interaction (p=0.021), indicating influenza infection differentially altered 
TNF-α expression in standard versus enriched mice (Figure 4.5B). SE FLU mice had increased 
TNF-α compared to both SE CON (p<.0001), as well EE FLU (p=0.0354). While influenza 
infection increased TNF-α expression overall, this increase was attenuated in enriched mice. 
For IL-6, IFN-α, and IFN-β there was a significant main effect of treatment (p<.0001), but no 
interaction between housing and treatment, indicating that influenza increased the expression of 
these cytokines to a similar extent in standard-housed and enriched mice (Figure 4.5C, Figure 
4.6A,B). 
 
Effects of environmental enrichment and influenza on hippocampal neurotrophic and 
immunomodulatory factors 
Neurotrophins 
For BDNF expression (Figure 4.7A), there was an effect of housing (p<.0001), with 
enriched animals having increased hippocampal BDNF expression. There was also an effect of 
treatment (p=0.0001), indicating that influenza decreased BDNF in both enriched and standard 
housed mice.  Although there was no housing x treatment interaction (p=0.5551), post-hoc 
analysis showed that EE FLU mice had more hippocampal BDNF that SE FLU mice (p=0.008), 
and maintained BDNF expression to levels comparable to the SE CON group (p=0.782). For 
NGF expression (Figure 4.7B), there was an effect of treatment (p<.0001), but no housing x 
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treatment interaction (p=0.190) indicating that influenza decreased NGF in both standard 
housed and enriched mice. In addition there was no main effect of housing on NGF expression 
(p=0.369), indicating that unlike BDNF, environmental enrichment did not increase NGF 
expression in the hippocampus.  
 
Immunomodulatory factors 
For CX3CL1 (Figure 4.7C), a main effect of treatment (p<.0001), with no housing x 
treatment interaction (p=0.968), indicated that influenza reduced CX3CL1 expression in mice 
from both environments. Interestingly, there was a main effect of housing (p=0.0069), in which 
environmental enrichment increased hippocampal CX3CL1 expression.  The effect of housing 
on CX3CL1 was driven by EE CON mice expressing more CX3CL1 than SE CON mice 
(p=0.040), and a trend (p=0.061) in which EE FLU mice maintained more CX3CL1 expression 
than SE FLU mice. For CD200 (Figure 4.7D), there was no effect of housing (p=0.138), but 
there was a main effect of treatment (p=0.012) with influenza decreasing CD200 expression. 
The interaction of housing x treatment approached significance (p=0.063), and post-hoc 
analysis revealed that only SE FLU had significantly reduced levels of CD200 following 
influenza infection (p<.05 compared to all other groups). Environmental enrichment blocked the 
influenza-induced decrease in CD200 as indicated by no difference in the levels of CD200 in the 
hippocampus of EE FLU mice when compared to both SE CON (p=0.430) and EE CON groups 
(p=0.599).    
 
Effects of environmental enrichment on influenza viral infection and cytokine levels in 
the lungs 
The data analysis indicated that on day 7 post-inoculation, influenza virus M1 expression 
was attenuated in the lungs of EE FLU mice when compared to SE FLU mice (p=0.0003) 
(Figure 4.8A). Influenza M1 gene expression was non-detectable (ND) in the lungs of control 
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mice. In addition, similar to our previous findings (Jurgens et al., in submission), there was no 
evidence of M1 gene expression in the hippocampus of control or infected mice (data not 
shown). For all antiviral and inflammatory cytokines, a main effect of treatment (p< .001 for all), 
indicated that influenza infection increased the expression of these cytokines in the lungs of 
both EE FLU and SE FLU groups (Figures 4.8 and 4.9). While there was no main effect of 
housing, or housing x treatment interaction for any of the cytokines, post-hoc analysis revealed 
that EE FLU mice had decreased expression of IFN-α (p=0.015), and IFN-β (p=0.014) when 
compared to SE FLU mice (Figure 4.8A,B and Figure 4.9B). Enrichment did not reduced the 
expression of IFN-γ (p=0.285), IL-1β (p=0.947), IL-6 (p=0.053), or TNF-α (p=0.474) (Figure 
4.8D and Figure 4.9A,C). 
 
4.5 Discussion 
While the effects of environmental enrichment (EE) on the brain and behavior have been 
explored in healthy animals, and in models of neuropsychiatric disease and neurodegeneration 
(van Praag et al., 2000; Laviola et al., 2008), its potential therapeutic role during infectious 
disease remains less understood. In the present study, we determined if long-term exposure to 
EE would have beneficial effects on the brain and behavior in a mouse model of influenza 
infection. We found that environmental enrichment helped attenuate the sickness response and 
cognitive dysfunction associated with influenza infection. In addition, environmental enrichment 
buffered the influenza-induced alterations in hippocampal expression of inflammatory, 
neurotrophic, and immunomodulatory factors. These novel findings suggest that a non-invasive, 
non-pharmacological intervention such as environmental enrichment can help ameliorate the 
negative cognitive effects of peripheral infection. In regard to central function, this may be due to 
increased resiliency of the enriched brain to neuroinflammation, and/or the preservation of 
neuroimmune communication between neurons and microglia.  
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Environmental enrichment attenuates influenza-induced cognitive deficits 
Overall, the data indicated the EE was moderately protective against influenza-induced 
deficits in hippocampal-dependent spatial learning and memory. Enriched influenza-infected 
mice showed improved performance during both acquisition training and the probe trial when 
compared to infected mice in standard housing conditions. Influenza-infected mice from both 
housing conditions were impaired during reversal testing, suggesting that when task difficulty is 
increased, or cognitive flexibility is needed, influenza-induced deficits are revealed. While 
hippocampal dysfunction can impede spatial reversal learning (Whishaw and Tomie, 1997), the 
frontal cortex plays an important role in the behavioral flexibility associated with reversal tasks 
(Kesner and Churchwell, 2011), and additional studies to determine the impact of influenza 
infection on this region are warranted.  
In our previous study (Jurgens et al., in submission), we also found deficits during 
reversal learning in influenza infected mice, but did not find influenza-induced impairment during 
acquisition or the probe trial. This difference is likely attributed to the use of a larger maze in the 
present study. Since it has been shown that enriched mice demonstrate superior performance in 
the water maze (van Praag et al., 2000), a larger maze was utilized in the present study to 
prevent a “ceiling effect” from interfering with the detection of environmental or influenza-
induced alterations in spatial learning and memory. Previous work has demonstrated that maze 
diameter significantly affects the acquisition and retention of spatial information in the water 
maze, and mice that perform well in smaller mazes, can demonstrate cognitive impairment 
when a larger maze diameter is employed (Van Dam et al., 2006; Vorhees and Williams, 2006). 
Overall, the results suggest that influenza-induced cognitive impairments are revealed when the 
difficulty of the task is increased, either by the use of larger maze or during reversal testing. 
Most importantly, influenza-infected EE mice demonstrated performance comparable to non-
infected mice by the end of acquisition training and during the probe trial, suggesting that 
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environmental enrichment helps buffer the deleterious effects of influenza infection on 
hippocampal-dependent cognitive behavior. 
 
Environmental enrichment attenuates influenza-induced hippocampal neuroinflammation 
A potential contributing factor to cognitive detriment during influenza infection is 
hippocampal inflammation. While the central cytokine response to peripheral infection is 
essential for mounting an appropriate immune response, and inducing adaptive sickness 
behaviors (Hart, 1988; Konsman et al., 2002), elevated or prolonged exposure to inflammatory 
mediators can have detrimental effects on cognitive and emotional behaviors (McAfoose and 
Baune, 2009; Yirmiya and Goshen, 2011). Similar to our previous findings, influenza infection 
increased expression of IL-1β, IL-6, TNF-α and IFN-α in the hippocampus of standard housed 
mice.  Most interestingly, environmental enrichment attenuated the influenza-induced increase 
in both IL-1β and TNF-α expression.  As IL-1β in particular is known to specifically impact 
hippocampal-dependent tasks (Goshen et al., 2007; Hein et al., 2010), the EE-induced 
modulation IL-1β expression could help preserve normal cognitive function during influenza 
infection.  In addition, since IL-1β has been shown to interfere with BDNF signaling (Barrientos 
et al., 2004; Tong et al., 2008), reducing IL-1β during infection could help maintain neurotrophic 
support and protect brain function.  Additional neuroprotective effects of EE could be afforded 
by the attenuation of the influenza-induced increase in hippocampal TNF-α, which can impact 
synaptic plasticity, and at increased levels contribute to neurodegeneration (Pickering and 
O'Connor, 2007; McCoy and Tansey, 2008). As enrichment only attenuated IL-1β and TNF-α, 
and did not prevent the increase in IL-6, IFN-α or IFN-β, which have also been shown to impact 
hippocampal function and cognition (Sparkman et al., 2006; Beyer et al., 2009; Sas et al., 
2009), this may help explain why enriched mice showed improved cognitive performance, but 
not complete rescue from deficits following influenza infection.  
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Environmental enrichment modulates the impact of influenza infection on neurotrophic 
and immunoregulatory factors 
As substantial evidence suggests that neurotropic factors play an important role in 
learning and memory and hippocampal plasticity (Tyler et al., 2002; Waterhouse and Xu, 2009), 
the influenza-induced reduction in hippocampal BDNF could have deleterious effects on 
cognitive function during influenza infection. While BDNF expression was blunted by influenza 
infection in both EE and SE mice, enriched mice maintained BDNF levels comparable to that of 
standard housed non-infected mice. As recent work has shown that even low levels of 
neurotrophic overexpression in the hippocampus can attenuate epileptogenic 
neuroinflammation and prevent IL-1β expression (Bovolenta et al., 2010), the higher levels of 
BDNF in the hippocampus of enriched mice could provide neuroprotection and modulate 
inflammation.   
In addition to increasing BDNF, we also found that enrichment increased the expression 
of CX3CL1 (fractalkine), a chemokine constitutively expressed in the brain, that exerts 
immunomodulatory and anti-inflammatory effects during acute and chronic neuroinflammation 
(Harrison et al., 1998; Zujovic et al., 2001; Cardona et al., 2006; Lyons et al., 2009). While well-
known for its role in immune function, recent evidence suggests that disruption of CX3CL1 
signaling can inhibit neurogenesis (Bachstetter et al., 2011), impair microglia-mediated synaptic 
pruning in the hippocampus (Paolicelli et al., 2011), and prevent the enhancement of neuronal 
plasticity and spatial cognition induced by environmental enrichment (Maggi et al., 2011), 
suggesting it may play an important role in hippocampal function.  While CX3CL1 was reduced 
by influenza in both enriched and standard-housed mice, the prior EE-induced increase in both 
BDNF and CX3CL1 could set the stage for constrained induction of neuroinflammation and 
better maintenance of neuronal structural and synaptic plasticity during viral infection. 
The ability of EE to completely prevent the influenza-induced decrease in CD200 could 
be a critical factor in maintaining essential neuron-microglia interactions during influenza 
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infection. While it is known that CD200 is important for keeping microglia in a resting state in 
both the healthy and diseased brain (Hoek et al., 2000; Chitnis et al., 2007), recent evidence 
suggests that constitutive expression of CD200 is essential for normal hippocampal plasticity 
and resiliency from inflammatory stimuli (Costello et al., 2011). In addition, it was recently shown 
that hippocampal dendrites express high levels of CD200, suggesting a role for this immune 
mediator in glial-synaptic interactions (Ojo et al., 2011). As we have previously shown that 
influenza infection induces hippocampal dendritic atrophy (Jurgens et al., in submission), this 
could contribute to decreased expression of CD200 in the hippocampus of standard-housed 
infected mice. While future work is needed to determine the influence of EE on neuronal 
architecture during influenza infection, it is possible that enrichment could reduce neuronal 
atrophy and help preserve CD200 levels in the hippocampus of influenza-infected mice. Overall, 
the maintenance of physiological levels of CD200 in the hippocampus of enriched mice during 
influenza infection may reduce neuronal vulnerability to inflammation and help maintain neuron-
glia interactions important in synaptic function.  
 
Effect of environmental enrichment on viral infection and immune response in the lungs 
While environmental enrichment reduced proinflammatory cytokine production in the 
brain during influenza infection, there was no effect of EE on the expression of IL1-β, IL6 or 
TNF-α in the lungs of infected mice. However, enrichment did reduce influenza viral load (as 
measured by influenza M1 expression) in the lungs of infected mice, and this was paralleled by 
the reduction of antiviral interferons, IFN-α and IFN-β. While the type-1 interferon response is 
essential to control viral replication (Wolff and Ludwig, 2009), prolonged or excessive cytokine 
activity leads to respiratory pathology and increased mortality during influenza infection (Van 
Reeth, 2000; La Gruta et al., 2007). The modulated (but not absent) antiviral response, along 
with reduced viral load and less body weight loss over the course of infection, suggests 
enriched mice were better able to cope with the viral infection.  While not addressed in the 
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current study, it has been shown that EE can alter NK and T cell activity (Benaroya-Milshtein et 
al., 2004; Marashi et al., 2004) which could influence the immune response during infection, as 
these cell populations play a vital role in the control of influenza viral infection (Culley, 2009; Kim 
et al., 2011). 
In addition, previous work has demonstrated that moderate exercise following infection 
with influenza virus reduced lung cellular infiltrate and pathology, and increased survival in adult 
mice (Lowder et al., 2006). Similar to our findings, these studies found there to be no reduction 
in lung IL1-β or TNF-α expression, but interferon levels were reduced, and there was tendency 
toward reduction of influenza M1 expression at day 3 and 5 post-infection. Taken together, 
these findings suggest it is likely that some portion of the beneficial impact of EE during 
influenza infection is afforded by the effects of increased physical activity. Indeed, exercise has 
been shown to modulate both the peripheral and central immune response (Packer et al., 2010; 
Walsh et al., 2011), as well as exert positive effects on brain morphology, plasticity, and 
cognition (Cotman et al., 2007; van Praag, 2009). While additional studies could determine the 
extent to which individual components of enrichment (i.e. physical activity, social or cognitive 
stimulation) effect the peripheral versus central immune response to influenza infection,  
evidence suggests that at least in terms of the brain, the greatest benefits are gained from 
additive or synergistic effects of the full repertoire of environmental enrichment (Faherty et al., 
2003; Leggio et al., 2005; Sozda et al., 2010).  
 
The impact of environmental enrichment on the neuroimmune response 
While the beneficial effects of environmental enrichment have primarily focused on 
changes in neuronal morphology, synaptic plasticity, and neurogenesis, EE also induces 
changes in non-neuronal components including cerebrovasculature, oligodendrocytes, and 
astrocytes (Soffie et al., 1999; Markham and Greenough, 2004; Viola et al., 2009). While less is 
known regarding the effects of EE on microglia, evidence suggests that they are also 
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responsive to physical and cognitive stimulation.  Previous work has found that enriched adult 
rats had increased numbers of microglia in the dentate gyrus that displayed a phenotype 
associated with neuroprotection and enhanced neurogenesis (Ziv et al., 2006). In a model of 
neurodegeneration, EE was shown to shift microglia from a neurotoxic to phagocytic phenotype 
that was associated with  reduced amyloid burden, upregulation of anti-inflammatory factors, 
and improvements in learning and memory (Dong et al., 2007). Overall these data suggest that 
environmental enrichment can promote a microglia phenotype associated with reduced 
inflammation and increased neuroprotection in both health and disease. 
While these exciting findings suggest that microglia are sensitive to enriched conditions,  
there is very little data regarding the impact of EE on the central immune response to infectious 
disease. Previous work has investigated the effects of EE in models of direct CNS infection, and 
while one study found no benefit on neurogenesis or spatial learning when implemented after 
infection with bacterial meningitis (Tauber et al., 2009), another study found mice reared in EE 
to have less viral neuroinvasion, reduced microglial activation, and improved behavioral 
outcome in a model of neurotropic viral encephalitis (de Sousa et al., 2011).  
To our knowledge the present study is the first to implement enrichment during 
peripheral viral infection and extend findings of the beneficial effects of environmental 
enrichment on CNS function to a highly pathogenic and clinically relevant respiratory disease. 
The ability of enriched mice to better modulate the brain’s response to peripheral infection could 
contribute to more efficient maintenance of CNS homeostasis during influenza infection, thus 
allowing for improved preservation of cognitive function. The protective effects of EE during 
influenza infection may be related to the development of brain and cognitive reserve, in which a 
physically and mentally active lifestyle promotes brain resiliency through more efficient and 
flexible networks that are less susceptible to disruption induced by injury or neurodegeneration 
(Petrosini et al., 2009). While environmental enrichment itself is a simple, non-invasive 
therapeutic that can provide resiliency and reserve during brain insult, injury or inflammation, the 
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elucidation of the mechanisms underlying the positive effects of environmental enrichment could 
help in the implementation of more specific interventions aimed at protecting neural function 
during peripheral infection. 
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4.6 Figures 
 
 
 
 
Figure 4.1.  Enriched environment cage. Environmental enrichment consisted of social 
interaction (n=5-8 mice in the cage), stimulation of exploratory behavior with objects such as 
toys and a set of tunnels, shelters, nesting materials, multiple locations of food and water ad 
libitum, and running wheels for voluntary exercise.   
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Figure 4.2.  Change in body weight following influenza infection. Influenza infection induced 
loss of body weight in both standard environment (SE) and enriched environment (EE) influenza 
mice. Influenza-infected mice in SE lost more body weight at day 5-7 post-inoculation than 
infected EE mice. Data are represented as means ± SEM.  (*p< 0.05 compared to treatment 
controls, # p< 0.05 SE FLU vs. EE FLU mice). 
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Figure 4.3.  Morris water maze acquisition and probe trial. (A) Distance to reach the hidden 
platform over 5 days of acquisition training (#p< 0.01 EE CON vs. SE CON and SE FLU; * p< 
0.01 SE FLU vs. all other groups). (B) Percent time spent in target quadrant during probe trial 
performed 24 hours after the last day of acquisition training. Means with different letters (a,b) 
are significantly different (p< 0.05) from each other.  
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Figure 4.4.  Morris water maze reversal testing.  Distance (pathlength) to reach the platform 
during reversal testing. Means with different letters (a,b) are significantly different (p< 0.05) from 
each other. 
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Figure 4.5.  Impact of environment and influenza infection on hippocampal proinflammatory 
cytokine expression at day 7 post-inoculation. Environmental enrichment attenuated the 
influenza-induced increased in IL-1β (A) and TNF-α (B).  Influenza infection induced IL-6 in both 
standard and enriched mice (C). Means with different letters (a,b,c) are significantly different (p 
< 0.05) from each other.  
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Figure 4.6.  Impact of environmental enrichment and influenza infection on hippocampal 
interferon cytokine expression at day 7 post-inoculation. Influenza infection induced IFN-α (A) 
and IFN-β (B) in both standard and enriched mice. Means with different letters (a,b) are 
significantly different (p < 0.05) from each other.  
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Figure 4.7.  Impact of environmental enrichment and influenza infection on hippocampal 
neurotrophic and immunomodulatory factor expression at day 7 post-inoculation. (A) 
Environmental enrichment attenuated the influenza-induced decrease in BDNF. (B) Influenza 
infection reduced NGF in both standard and enriched mice. (C) Influenza infection reduced 
CX3CL1 in both standard and enriched mice. (D) Environmental enrichment attenuated the 
influenza-induced decrease in CD200. Means with different letters (a,b,c,d) are significantly 
different (p < 0.05) from each other.  
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Figure 4.8.  Impact of environmental enrichment and influenza infection on expression of 
influenza virus and cytokines in the lung at day 7 post-inoculation. (A) Environmental 
enrichment attenuated the expression of influenza matrix (MI) protein. M1 expression was non-
detectable (N.D.) in control samples. Environmental enrichment attenuated the influenza-
induced increase in expression of IFN-α (B) and IFN-β (C). Influenza infection induced IFN-γ in 
both standard and enriched mice (D). Means with different letters (a,b,c) are significantly 
different (p < 0.05) from each other. 
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Figure 4.9.  Impact of environmental enrichment and influenza on expression of inflammatory 
cytokines in the lung at day 7 post-inoculation. Influenza infection induced IL-1β (A), IL-6 (B) 
and TNF-α (C) in both standard and enriched mice. Means with different letters (a,b) are 
significantly different (p < 0.05) from each other.  
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CHAPTER 5 
CHANGES IN HIPPOCAMPAL GENE EXPRESSION AND COGNITIVE FUNCTION 
DURING RECOVERY FROM INFLUENZA INFECTION 
 
5.1 Abstract 
Previous studies from our lab have shown that peripheral infection of adult mice with live 
influenza virus induces a neuroimmune response in the hippocampus, and deficits in spatial 
learning and memory. In addition, influenza-infected mice show decreased hippocampal 
expression of neurotrophic and glial regulatory factors necessary for neuron-microglia 
interactions and the proper support of neuronal structure and function. These deleterious effects 
were found during acute influenza infection when symptoms of sickness behavior were evident, 
but it is unknown how long these changes continue over the course of infection. As there is 
evidence of long-lasting consequences of viral infection on emotional and cognitive behavior, 
the objective of this study was to determine if increased neuroinflammation and the loss of 
neurotrophic support persist during and after recovery from illness, and moreover, examine if 
this has lasting consequences on cognitive function.  
 
5.2 Introduction 
The purpose of this study was to extend previous work investigating the impact of 
influenza infection on cognitive function and hippocampal expression of inflammatory, 
neurotrophic and immunomodulatory factors. In previous studies, mice that were administered 1 
hemagglutinating unit (HAU) influenza A/PR8/34 virus demonstrated cognitive dysfunction, 
neuroinflammation, and the loss of neurotrophic and immune regulatory factors at day 7 post-
inoculation. While previous studies (Lowder et al., 2005) have shown that during influenza 
infection, mice can lose a substantial amount of body weight (30-35%) and still recover, as an 
established humane endpoint, mice that reached a 30% loss of their initial body weight were 
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euthanized. To determine if influenza produces longer lasting changes in hippocampal function 
and gene expression, the present study utilized a lower dose (0.3 HAU) of influenza virus that 
produced a similar level of influenza-induced sickness behavior and weight loss, but allowed for 
full recovery following infection (also see Appendix B). Changes in bodyweight, nest building 
behavior, and locomotor activity were assessed throughout disease progression and recovery. 
Following recovery, cognitive behavior was assessed in a reversal learning version of the Morris 
water maze. In addition, levels of inflammatory, neurotrophic and immune regulatory factors 
were measured at peak sickness, partial recovery, and full recovery from infection to determine 
how long influenza-induced alterations in hippocampal gene expression persist. 
 
5.3 Materials and Methods 
Animals 
For all studies, adult (4-6 months old) male Balb/c mice from our in-house colony were 
used. Mice were individually housed in polypropylene cages under a reverse 12:12 hour 
light:dark cycle at 24°C and given ad libitum access to food and water. All animal care and 
experimental procedures are in accordance with the National Institute of Health Guidelines for 
the Care and Use of Laboratory Animals and approved by the University of Illinois Institutional 
Animal Care and Use Committee. 
 
Mouse viral infection     
Mouse-adapted human influenza A/Puerto Rico/8/34 (H1N1) virus was a generous gift 
from Dr. John Sheridan and Dr. David Padgett (The Ohio State University). Mice were lightly 
anesthetized with isoflurane and intranasally (i.n.) inoculated with 0.3 hemagglutinating unit 
(HAU) of influenza A/PR/8/34 virus in 50 µl sterile PBS. Control animals were inoculated (i.n.) 
with 50 µl of sterile PBS. Use of isoflurane anesthesia allowed for quick recovery (<2min) and 
accurate delivery of viral dose. Following viral infection, mice were monitored daily for signs of 
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morbidity including response to handling, food intake, and physical appearance (ruffled fur, 
huddled or hunched behavior).  In addition, changes in body weight, nest building behavior, and 
locomotor activity were used as more objective measures of disease progression. In mouse 
models of influenza, weight loss is considered a reliable indicator of disease progress 
(Matsuoka et al., 2009), thus body weight was measured at the same time daily (between 
09:00-10:00) and percent change from initial body weight (day 0) was calculated. 
 
Nest building behavior 
Nest building is a species-specific behavior, and both male and female mice make nests 
for heat conservation, shelter, and protection from predators (Van de Weerd et al., 1997). 
Monitoring of nest building activity provides a noninvasive assessment of behavioral deficits, 
and has been shown to be sensitive to hippocampal disruption due to damage and prion 
disease (Deacon et al., 2002; Cunningham et al., 2003). To measure influenza-induced 
changes in nest building behavior, mice were given a new Nestlet daily, and the quality of nests 
were scored each morning (between 09:00-10:00) according to a five-point scale (Deacon, 
2006):  
1. Nesting material (Nestlet) was not noticeably used (less than 10% shredded) 
 2. Nestlet was partially shredded (10-50% is shredded) 
 3. Nestlet was 50-90% shredded but was erratically spread about the cage 
 4. Nestlet was at least 90% shredded but nest was flat and spread out with no walls 
 5. A (near) perfect nest, the Nestlet was >90% shredded into a crater with walls built up 
 
Locomotor behavior 
Spontaneous locomotor activity was measured prior to intranasal inoculation (day 0), 
and for 25 days following inoculation in order to investigate acute sickness behavior and 
recovery during influenza infection. Behavioral testing was conducted during the dark phase 
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(between 09:00-11:00) of the photoperiod under infrared lighting to aid video recording. Mice 
were maintained in their home cage and locomotor activity was video recorded during 5 minute 
tests. A computerized animal tracking system (Ethovision; Noldus Information Technologies) 
was used to measure total distance moved during the testing period.  
 
Morris water maze 
The effects of influenza infection on spatial learning and memory were assessed in a 
reversal learning version of the Morris water maze as previously described (Jurgens et al., in 
submission). At day 21 post-inoculation, mice began 4-day acquisition phase (day 21-24 post-
inoculation). The platform remained in the same location during the acquisition training.  On day 
25 post-inoculation (24 h after the last day of acquisition training), the platform was removed 
and mice received a 30 s probe trial to assess spatial memory for the platform location. 
Following the probe trial, mice were subjected to a reversal test in which the hidden platform 
was moved to the opposite quadrant of the pool, but all distal visual cues remained constant. A 
video camera in conjunction with a computerized animal tracking system (Ethovision; Noldus 
Information Technologies) was used to record swim speed, latency to the platform, and distance 
swam (pathlength to the platform). Since latency to reach the platform can be affected by motor 
function (swim speed) and motivation, distance swam (pathlength) is considered a more reliable 
measure of learning and memory performance (Contet et al., 2001; Cunningham and 
Sanderson, 2008), and therefore was used determine the performance of mice during both 
acquisition training and reversal testing. 
 
Quantitative real-time PCR 
Mice were euthanized by CO2 asphyxiation and blood and tissue samples were quickly 
collected and stored in RNAlater at –80°C. Total RNA was isolated from homogenized tissue 
using the Tri Reagent protocol (Sigma, St. Louis, MO). A QuantiTect Reverse Transcription Kit 
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(Qiagen, Valencia, CA) was used for cDNA synthesis with integrated removal of genomic DNA 
contamination according to the manufacturer protocol. Quantitative real-time PCR was 
performed using the Applied Biosystems (Foster, CA) Assay-on Demand Gene Expression 
protocol. In short, cDNA was amplified by PCR where a target cDNA (IL-1β, IL-6, TNF-α, IFN-α, 
BDNF, NGF, CD200 and CX3CL1) and a reference cDNA (glucose-3 phosphate 
dehydrogenase) were amplified simultaneously using an oligonucleotide probe with a 5′ 
fluorescent reporter dye (6-FAM) and a 3′ quencher dye (NFQ). PCR reactions were performed 
at the following conditions: 50 °C for 2 min, 95 °C for 10 min, followed by 40 cycles of 95 °C for 
15 s, and 60 °C for 1 min. Fluorescence was determined on an ABI PRISM 7900HT-sequence 
detection system (Perkin Elmer, Forest City, CA). Data were analyzed using the comparative 
threshold cycle (Ct) method, and results are expressed as fold change (Schmittgen and Livak, 
2008).  
 
Experimental design 
In the first study, mice (n=6-8 per group) were inoculated with 0.3 HAU influenza virus 
(or PBS control), and body weight, nest building and locomotor activity were monitored daily for 
25 days post-inoculation. This group of mice underwent cognitive testing in the Morris water 
maze from day 21-25 post-inoculation, and following behavior testing, mice were euthanized 
and tissues were collected for analysis. In a separate study, mice (n=5-6 per group) were 
inoculated with 0.3 HAU influenza virus (or PBS control), and tissue was collected at day 7 and 
14 post-inoculation to determine changes in hippocampal gene expression during peak sickness 
(d7) and partial recovery (d14) from influenza infection. 
 
Statistical Analysis 
Data for body weight, nest building, locomotor activity, and water maze acquisition were 
subjected to a repeated measures ANOVA using treatment (control vs. influenza) as the 
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between-subjects factor.  The within-subjects factor for body weight, nest building, and 
locomotor activity was day post-inoculation, while the within-subjects factor for water maze data 
was day of acquisition training. All other data (gene expression, water maze reversal test and 
probe trial) were analyzed using a 1-way ANOVA in which treatment (control vs. influenza) was 
the independent variable. When the ANOVAs revealed a significant main effect or interaction 
between main factors, post hoc Student’s t-test using Fisher’s least significant differences was 
employed to determine if treatment means were significantly different from one another 
(p<0.05). Planned comparisons for gene expression data collected at intervals post-inoculation 
(p.i.), compared control vs. day 7 p.i.; control vs. day 14 p.i., and day 7 vs. day 14 p.i. to 
determine if means were significantly different from each other. All data are presented as means 
± SEM. 
 
5.4 Results/Discussion 
Influenza-induced sickness behavior 
Changes in bodyweight, nest building behavior and locomotor activity were used to 
measure the sickness response and recovery phase during influenza infection. For body weight 
data, repeated measures ANOVA revealed an effect of treatment (p<.0001), day (p<.0001), and 
treatment x day interaction (p<.0001), indicating that mice infected with influenza lost more body 
weight than controls over the 25-day post-inoculation timecourse (Figure 5.1A). Loss of 
bodyweight peaked around day 9 p.i., at which point mice began to slowly gain weight, but 
continued to weigh approximately 5% less than control animals for the remainder of the study. 
The analysis of the nest building behavior showed an effect of treatment (p=.0015), day 
(p<.0001), and treatment x day interaction (p<.0001), indicating the influenza infected mice 
reduced nest construction over the course of influenza infection (Figure 5.1B). Nest building 
behavior was maximally decreased at days 6-8 p.i., when influenza infected mice only used 
approximately 10-50% of their Nestlet as assessed by the scoring system. Over days 9-13 p.i., 
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infected mice rapidly recovered nest building behavior, and by day 14 p.i., there was no 
significant difference in the nest scores of influenza infected mice and control mice.   
For the locomotor activity data, repeated measures ANOVA showed no main effect of 
treatment (p=.2485), but an effect of day (p<.0001), and a treatment x day interaction (p<.0001) 
suggested that at different timepoints post-inoculation, locomotor activity was differentially 
affected by influenza infection. Locomotor activity was lowest at day 7 p.i. and returned to 
control levels by day 14 post-inoculation (Figure 5.1C).  
In visualizing the locomotor data, a pattern was evident in which the activity of influenza 
infected animals appeared elevated compared to controls during the period of Morris water 
maze testing (day 21-25 post-inoculation). Therefore, data from days 0-20 p.i., and days 21-25 
p.i., were separated and individually subjected to repeated measures ANOVA for further 
investigation. The analysis of locomotor activity over days 0-20 p.i. showed a main effect of 
treatment (p=.0493), as well as an effect of day (p<.0001), and a treatment x day interaction 
(p<.0001), indicating that locomotor activity was depressed in influenza infected mice over this 
period. The analysis of locomotor activity over days 21-25 p.i. showed a main effect of treatment 
(p=.0265), but no effect of day (p=.1617), or day x treatment interaction (p=.5856), indicating 
that influenza infected mice had increased locomotor activity compared to control animals 
during the timeframe in which Morris water maze testing took place.  It is important to note that 
locomotor activity was recorded in the home cage of mice before they were tested in the water 
maze, so the increase in spontaneous activity was not (directly) induced by water maze testing. 
While the mechanisms underlying the increase in locomotor activity exhibited by mice recently 
recovered from influenza infection remain unknown, it is possible that increased locomotor 
activity is indicative of increased food seeking behavior, perhaps in response to the influenza-
induced loss of body weight. Increased locomotor activity has been shown to occur in mice 
during conditions of negative energy balance due to food deprivation (and loss of body weight) 
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as a means of increased food foraging and/or maintaining body temperature (Gelegen et al., 
2006; Wang et al., 2006). 
 
Influenza-infected mice are not impaired in the Morris water maze following recovery 
from influenza infection 
For the water maze acquisition data, repeated measures ANOVA revealed an effect of 
day (p <.0001), but no effect of treatment (p = .8245) or treatment x day interaction (p = .6867), 
indicating that during acquisition, both control and infected mice demonstrated improved 
performance (shorter pathlength) over testing days, and appeared to acquire the task at the 
same rate (Figure 5.2A). In addition, there was no effect of treatment for the probe trial 
(p=0.6721) (Figure 5.2B), or the reversal test (p=0.6807) (Figure 5.2A), implying that influenza 
infected mice were not impaired in their memory retention for the platform location, or in their 
ability to update their search strategy during reversal learning. Overall, these data suggest that 
influenza infection does not produce deficits in spatial cognition that persist following recovery.  
Additional studies could determine if cognitive dysfunction is still present at earlier timepoints in 
the recovery process to further elucidate how long changes in cognition continue beyond the 
acute sickness response.  
 
Changes in hippocampal gene expression during and following recovery from influenza 
infection 
Changes in the levels of inflammatory, neurotrophic, and immunomodulatory factors 
were determined at day 7 and 14 post-inoculation to determine the effect of influenza infection 
on hippocampal gene expression during peak sickness and partial recovery, respectively.  Day 
7 p.i. was chosen to represent the peak sickness response, as nest building and locomotor 
activity reached the lowest value at this time. In addition, measuring changes at this timepoint 
allowed for comparison to previous studies in which data was collected at day 7 post-inoculation 
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at a higher (1 HAU) viral dose (Jurgens et al., in submission). Day 14 p.i. was chosen to 
represent partial recovery, as this is the earliest timepoint in which nest building and locomotor 
activity reached control values, but bodyweight was still significantly reduced. 
Similar to our previous studies, we found an increase in inflammatory cytokines IL-6 
(p=0.0032), TNF-α (p=0.0291) and IFN-α (p=0.0394) in the hippocampus of influenza infected 
mice compared to controls at day 7 post-inoculation (Figure 5.3A). While at the 1 HAU dose 
used in previous studies there was a significant increase in IL-1β at day 7 p.i, at the lower dose 
used here (0.3 HAU), IL-1β was not significantly increased (p=0.1376). However, IL-1β was 
increased at day 14 p.i. when compared to control mice (p=0.0493). At day 14, TNF-α also 
remained elevated (p=0.0159), while IL-6 (p=0.4070) and IFN-α (p=0.6550) were no longer 
increased compared to control mice (Figure 5.3A). 
Analysis of neurotrophic factor expression revealed that, unlike in our previous 
experiments at the 1 HAU dose, there was no influenza-induced decrease in the hippocampal 
expression of BDNF (p=0.4462) or NGF (p=0.1976) at day 7 post-inoculation when compared to 
control mice (Figure 5.3B). Since in our previous studies, neurotrophin expression was 
significantly decreased in influenza infected mice that had undergone water maze testing, it is 
possible that infection blunts activity-induced neurotrophin expression with less effect on basal 
expression (Chen et al., 2010; Kuczewski et al., 2010). Additional studies could compare 
neurotrophin expression at day 7 p.i. using the higher viral dose (1 HAU) in animals that have 
not undergone behavioral testing to examine this possibility. In addition, there was also no 
difference in the expression of BDNF (p=0.5753), or NGF (p=0.9125) at day 14 post-inoculation 
(Figure 5.3B), indicating that at this dose, neurotrophin levels in the hippocampus appear to be 
maintained throughout influenza infection.  
Analysis of hippocampal expression of immunomodulatory factors showed that, similar 
to our previous work, there was an influenza-induced decrease in CD200 (p=0.0026) and 
CX3CL1 (p=0.0164) when compared to control mice at day 7 post-inoculation (Figure 5.3B). By 
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day 14 p.i., there was no difference in the expression of levels of CX3CL1 (p=0.4503) when 
compared to controls, but the levels of CD200 remained decreased (p=0.0407). The prolonged 
reduction in CD200 could increase inflammation and impede normal neuronal function, as it has 
recently been shown that animals deficient in CD200 display impaired hippocampal synaptic 
plasticity and elevated basal expression of TNF-α in the hippocampus (Costello et al., 2011). 
Data collected from day 25 post-inoculation was analyzed separately as these animals 
underwent Morris water maze testing. The analysis of hippocampal gene expression data 
revealed no effect of influenza infection on the levels of inflammatory cytokines IL-1β 
(p=0.8838), IL-6(p=0.7439), TNF-α (p=0.6408) or IFN-α (p=0.2583) (Figure 5.4A). In addition, 
there was no effect of influenza infection on the expression of neurotrophins, BDNF (p=0.2928) 
and NGF (p=0.3841) or immunomodulatory factors CD200 (p=0.4429) or CX3CL1 (p=0.2638) 
(Figure 5.4B). Overall these data suggest that there do not appear to be long-lasting alterations 
in the hippocampal expression of these genes following recovery from influenza infection. 
 
Overall summary and conclusions 
The findings presented here provide a thorough investigation of changes in several 
behavioral measures of the sickness response induced by infection with live influenza virus, and 
establish that at this dose of viral infection, mice take at least 2-3 weeks to fully recover from 
influenza infection. Compared to sickness behavior induced by immune challenge with LPS (to 
mimic a bacterial infection), or Poly I:C (to mimic a viral infection), the sickness response and 
changes in hippocampal expression of proinflammatory cytokines following influenza infection is 
quite prolonged (days to weeks for influenza infection, versus 2-24 hours for mimetics). Overall, 
the data indicate that while the effects of influenza infection on inflammatory cytokines (IL-1β 
and TNF-α), and the neuroimmune regulatory factor CD200 are still evident two weeks following 
infection, changes in hippocampal gene expression of immune-related mediators and 
neurotrophic factors do not persist following complete recovery from infection. In addition, mice 
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that have recovered from influenza infection do not demonstrate long-lasting cognitive deficits in 
spatial learning and memory. Future work could determine if the low-level inflammation 
concurrent with prolonged reduction in glial regulatory factors resulting from influenza infection 
could leave the brain vulnerable to further insult, and/or primed to mount an exaggerated 
response to subsequent immune challenge.    
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Figure 5.1. Sickness behavior following influenza infection. Change in bodyweight (A), nest 
building (B), and locomotor activity (C) over the course of influenza infection. Mice were tested 
in the Morris water maze at days 21-25 post-inoculation. Data are represented as means ± 
SEM. (*p < 0.05, **p < 0.01 compared to controls). 
5.5 Figures 
127 
 
 
 
 
 
Figure 5.2.  Influenza infected and control animals demonstrated similar performance over 
acquisition training and during reversal (REV) testing as measured by distance to reach the 
hidden platform (A). A probe trial (24 hours following the last day of acquisition testing) indicated 
no significant difference in the amount of time influenza mice spent in the target quadrant 
compared to controls (B). 
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Figure 5.3.  Influenza induced changes in hippocampal gene expression at day 7 and day 14 
post-inoculation. (A) Inflammatory cytokines IL-1β, IL-6, TNF-α, and IFN-α. (B) Neurotrophic 
(BDNF, NGF) and immunomodulatory (CD200, CX3CL1) factors. Data are represented as 
means ± SEM. Means with different letters (a,b) are significantly different (p < 0.05) from each 
other. 
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Figure 5.4. Influenza induced changes in hippocampal gene expression at day 25 post-
inoculation (following Morris water maze testing). (A) Inflammatory cytokines IL-1β, IL-6, TNF-α, 
and IFN-α. (B) Neurotrophic (BDNF, NGF) and immunomodulatory (CD200, CX3CL1) factors. 
Data are represented as means ± SEM. Means with different letters (a,b) are significantly 
different (p < 0.05) from each other. 
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CHAPTER 6 
 
SUMMARY AND SIGNIFICANCE 
 
 
The broad aim of this research was to determine if peripheral infection with live influenza 
virus induces a central immune response and impacts hippocampal structure and function. The 
findings from Chapter 3 presented evidence that influenza infection resulted in hippocampal 
inflammation, reduced expression of immunomodulatory factors important for the neuronal 
control of microglial reactivity (Tian et al., 2009), and the loss of neurotrophins essential for 
neuronal support and plasticity (Poo, 2001).  At the same timepoint in which changes in 
hippocampal gene expression were evident, influenza-infected mice demonstrated impaired 
spatial cognition as assessed in a reversal learning version of the Morris water maze. Further 
studies in Chapter 3 helped elucidate potential cellular mechanisms underlying increased 
neuroinflammation and changes in cognitive function during influenza infection by 
demonstrating evidence of increased microglial reactivity, and alterations in the architecture of 
hippocampal neurons in the CA1 region and dentate gyrus. Together, these novel data are the 
first to suggest that changes in hippocampal structural plasticity may underlie cognitive 
dysfunction during influenza infection. Future work is needed to determine if these 
morphological changes are specific to influenza infection, or would also be evident in response 
to other viral pathogens. In addition, it is unknown if dendritic remodeling during infection is a 
mechanism to protect against permanent damage or if instead, it represents pathological 
atrophy which could enhance neuronal vulnerability to insult (McEwen, 2010; Emoto, 2011). 
Future studies using the (recoverable) lower dose of virus could determine if/when dendritic 
arbors return to a “normal” state following influenza infection. 
In Chapter 4, the efficacy of long-term environmental enrichment in preventing and/or 
attenuating some of the negative effects of influenza infection on the hippocampus and 
cognition was evaluated. Mice exposed to enriched conditions during rearing and throughout 
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infection were moderately protected from influenza-induced cognitive impairments, showed 
reduced hippocampal inflammation, and maintained higher levels of neurotrophins and glial 
regulatory factors. In addition, enriched mice also had reduced viral load in the lungs, and lost 
less body weight over the course of infection, suggesting that environmental enrichment may 
modulate both the peripheral and central immune response to viral infection. These data are the 
first to demonstrate neuroprotective effects of an enriched environment on the brain and 
behavior during peripheral viral infection. While environmental enrichment itself is a simple, non-
invasive therapeutic that can provide resiliency and reserve during brain injury or degeneration 
(Nithianantharajah and Hannan, 2009), the elucidation of the mechanisms underlying the 
positive effects of environmental enrichment could help in the implementation of more specific 
interventions aimed at protecting neural function during peripheral infection. 
The studies in Chapter 5 were meant to extend the previous findings by determining if 
influenza infection produced long-lasting changes in the hippocampus and/or lingering cognitive 
deficits following physical recovery. While the present study did not find evidence of long-term 
cognitive dysfunction in spatial learning and memory, further work is needed to determine if 
influenza results in neurobehavioral changes when assessed at earlier timepoints during 
recovery, and/or using other additional cognitive testing methods. The characterization of 
disease progression and recovery in a mouse model of influenza infection could provide a 
valuable tool for further investigation of the short and long-term effects of viral infection on a 
variety of neurobehavioral outcomes (depression, anxiety, stress) known to be altered by 
immune signaling in the brain ( (Dantzer et al., 2008; Capuron and Miller, 2011). In addition, 
future studies could implement this recovery model to determine if microglial priming induced by 
chronic low-level cytokine expression, along with the prolonged reduction in immunomodulatory 
factors, leads to an exaggerated central inflammatory response upon subsequent immune 
challenge similar to that observed in aged animals (Dilger and Johnson, 2008). It is possible that 
dysregulated neuron-glia communication with concurrent loss of neurotrophic support could 
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leave the brain vulnerable to further insult during or following influenza infection. A better 
understanding of how influenza infection alters the structure and function of the central nervous 
system will allow for the development of therapeutic strategies aimed at modulating the 
neuroimmune response and maintaining neuronal integrity during viral infection. 
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APPENDIX A 
TIMECOURSE OF CHANGES IN HIPPOCAMPAL GENE EXPRESSION FOLLOWING 
INFLUENZA INFECTION 
 
A.1 Background 
Results from our previous studies determined that influenza infected mice have 
increased expression of inflammatory cytokines (IL-1β, IL-6, TNF-α and IFN-α) and reduced 
levels of neurotrophic (BDNF, NGF) and neuroimmune regulatory factors (CD200, CX3CL1) in 
the hippocampus at day 7 post-inoculation (Jurgens et al., in submission). As inflammatory 
cytokines can alter neuronal structure and function (Milatovic et al., 2003; Richwine et al., 2008), 
and healthy neurons help maintain microglia in a physiological/resting state (Biber et al., 2007; 
Tian et al., 2009), it is important to better understand the timeframe in which alterations in 
neuron-microglia interactions may manifest during influenza infection. Therefore, mice (n= 4-5 
per group) were inoculated with 1 hemagglutinating unit (1 HAU) influenza virus (or PBS control) 
and hippocampal tissue was collected at day 1 and 4 post-inoculation (p.i.)  for determination of 
influenza-induced changes in hippocampal gene expression of inflammatory, neurotrophic and 
immunomodulatory factors. 
  
A.2 Results/Conclusions 
The analysis of gene expression data showed that there was no signficant effect of 
influenza infection at day 1 post-inoculation for the expression of any of the inflammatory 
cytokines (Figure A.1A), or neurotrophic and immunoregulatory factors (Figure A.1B). At day 4 
post-inocuation, influenza infection induced a significant increase in IL-1β (p=0.0123), IL-6 
(p=0.0042), and IFN-α (p=0.0384), while there was no effect of influenza infection on the levels 
of IL-6 (p=0.2293) at this timepoint when compared to control mice (Figure A.1A.). There was 
also no treatment effect at day 4 p.i. for the expression of neurotrophic factors BDNF (p=0.6173) 
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or NGF (p=0.1133), but CD200 was elevated (p=0.0022), and CX3CL1 was reduced (p=0.0034) 
in the hippocampus of infected mice when compared to controls (Figure A.1B). 
Taken together,  these findings suggest that  an increase in hippocampal inflammation at 
day 4 p.i. likely precedes the decrease in neurotrophic and immunomodulatory factors evident at 
day 7 p.i. in previous studies. This data helps to further elucidate the timecourse of changes in 
the hippocampal microenvironment during influenza infection, and may indicate that increased 
microglial reactivity and a neuroinflammatory state contribute to subsequent alterations in 
mediators of neuronal support and function. While CD200 was increased at day 4 p.i., previous 
work has shown that by day 7 p.i., CD200 is significantly blunted by influenza infection. It is 
possible that this early increase in CD200 is a compensatory mechanism to help control 
microglial activity as inflammation is increasing. A reduction in immunomodulatory factors has 
been shown to occur in states of chronic inflammation such as aging and neurodegeneration 
(Jurgens and Johnson, 2010), suggesting that changes in these regulatory factors may follow 
more prolonged expression of proinflammatory cytokines.   
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A.3 Figure  
 
 
 
Figure A.1. Influenza induced changes in hippocampal gene expression at day 1 and day 4 
post-inoculation. (A) Inflammatory cytokines IL-1β, IL-6, TNF-α, and IFN-α. (B) Neurotrophic 
(BDNF, NGF) and immunomodulatory (CD200, CX3CL1) factors. Data are represented as 
means ± SEM. Means with different letters (a,b) are significantly different (p < 0.05) from each 
other. 
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APPENDIX B 
DOSE-RESPONSE CURVES FOR CHANGE IN BODYWEIGHT FOLLOWING 
INFLUENZA INFECTION 
 
B.1 Background 
The 1 hemagglutinating unit (HAU) dose of influenza virus used in our experiments 
(Jurgens et al., in submission)  produced an extremely reliable disease progression in infected 
mice, as evidenced by the small amount of variation in both body weight loss, and locomotor 
activity (Figures 3.2 A,B). However, at this dose mice lost 30% of their initial body weight and 
had to be euthanized by day 7-8 post-inoculation (p.i.). While previous work (Lowder et al., 
2005) has shown that during influenza infection, mice can lose a substantial amount of body 
weight  (30-35%) and still recover, in the present studies, mice that reached a 30% loss of their 
initial body weight were euthanized as an established humane endpoint (Olfert and Godson, 
2000). Therefore, it was necessary to find a dose of influenza that produced robust and reliable 
sickness behavior, but from which mice could fully recover.  
 
B.2 Results/Conclusions 
In an initial dose-response study, mice (n = 3-4 per group) were infected with 0.1, 0.5 or 
1 HAU of influenza virus or (PBS control) and body weight was recorded daily to determine 
disease progression. In this study, the mice given both the 0.5 HAU (data not shown) and 1 
HAU doses lost 30% of their body weight, and had to be euthanized, while the animals at the 
0.1 HAU dose did not show a significant change in body weight compared to controls (Figure 
B.1). Therefore in the next study, the dose range was narrowed further, and mice (n = 3-4 per 
group) were infected with 0.25, 0.3, 0.4 or 1 HAU of influenza virus (or PBS control).  Mice 
infected with the 1 HAU lost 30% of their body weight and had to be euthanized as expected. 
(The 1 HAU dose was included in all experiments as in “internal control” to verify consistent 
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virus preparation and inoculation). Mice given the 0.25, 0.3 and 0.4 HAU dose had body weight 
loss that peaked around day 8-9 p.i., and showed full recovery by day 28-30 post-inoculation 
(Figure B.1). Based upon the findings of these dose-response studies, we chose to use the 0.3 
HAU dose, as this dose produced reliable disease progression and no mortality. We found 
subjective measures of sickness (food intake, nest building) to be more variable at the 0.25 
HAU dose, while in the 0.4 HAU group, one of the four mice had to be euthanized.  
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B.3 Figure  
 
 
 
 
Figure B.1 Change in bodyweight at different doses of influenza virus over 30 days post-
inoculation (HAU=hemagglutinating units). Mice inoculated with 1 HAU of influenza virus were 
euthanized at day 7 post-inoculation.  
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